Psoriasis Uncovered

National Psoriasis Foundation presents “Psoriasis Uncovered” (formerly Psound Bytes™), a podcast series about psoriasis and psoriatic arthritis featuring leading experts who discuss topics that offer a better understanding of the disease and management, to coping and thriving with the disease. Listen to world renowned dermatologists and rheumatologists discuss the latest news in psoriatic disease management.

Ep. 279 "To Test for TB or Not: Latest Recommendations for Psoriatic Disease Treatments" 06/18/2026

Ep. 279 "To Test for TB or Not: Latest Recommendations for Psoriatic Disease Treatments" Description: Do you wonder if TB testing is needed when on a biologic for psoriasis and/or psoriatic arthritis and why? Hear the answer to such questions and more from dermatologist Dr. G. Scott Drew as he addresses recent recommendations. Join host Archie Franklin as he discusses the latest recommendations from NPF and the International Psoriasis Council about routine testing for tuberculosis (TB) with treatments for psoriasis and psoriatic arthritis such as TNF-inhibitors, IL-17’s, IL-23’s and others with NPF Medical Board member and leading dermatologist Dr. G. Scott Drew from Mid-Ohio Dermatology. This episode identifies when a screening for tuberculosis (TB) is needed based on the type of treatment for psoriasis and psoriatic arthritis given recent recommendations from the National Psoriasis Foundation and the International Psoriasis Council. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. G. Scott Drew. (1:00) What is tuberculosis (TB) and why testing is required with TNF-alpha inhibitors. (4:22) Frequency of testing for TB and if false positive results occur. (6:15) Do other immunosuppressants require TB testing? (8:14) Testing may create barriers to access or unnecessary testing. (11:03) Release of new recommendations from the IPC and the NPF Medical Board offering guidance of when to test for tuberculosis prior to and during treatment of psoriatic disease. (15:37) No longer need to wait to start therapy like the IL-17’s or IL-23’s to see the impact on quality of life. (18:26) TB recommendations for other targeted medications like JAK inhibitors, PDE4, or the new oral IL-23 agent. (19:15) Implications of the recommendations for clinical trials. (20:13) Become a member of NPF and visit the website to access resources and stay aware of the latest information impacting the care and treatment of psoriasis and psoriatic arthritis. Key Takeaways: · Due to the contagious nature of tuberculosis, a mycobacteria infection that affects the lungs and other parts of the body, and the increased risk associated with suppressing TNF-alpha, a TB screening is required prior to initiating and during some treatments for psoriasis and psoriatic arthritis. · With more advanced and targeted psoriatic disease treatments now available, the National Psoriasis Foundation and the International Psoriasis Council joint position statement recommends that TB screening is no longer needed with use of IL-17 or IL-23 treatments. · TB screening may still be appropriate for specific populations and when symptoms are present based on a clinician’s assessment. Guest Bio: Dr. G. Scott Drew is a medical and surgical dermatologist with Mid-Ohio Dermatology Associates where he specializes in inflammatory diseases such as psoriasis, believing strongly in dermatology and patient care. He is board certified in both Dermatology and Family Practice. In addition to his clinical practice, Dr. Drew is a member of the clinical faculty at Ohio State University, College of Osteopathic Medicine and participates in multiple dermatologic research protocols at five locations in central Ohio. He has been published in numerous peer-reviewed journals, contributed to scientific symposia, and authored textbook chapters. Dr. Drew is a fellow of the American Osteopathic College of Dermatology and the American Academy of Dermatology, he is past president of the Marion Academy of Medicine, a member of the American Osteopathic Association, and is a member of the National Psoriasis Foundation’s Medical Board contributing to the development of guidelines and consensus statements. He is passionate about education providing lectures both nationally and internationally on medical, surgical, and cosmetic dermatology. Resources: Journal of the American Academy of Dermatology. Vol . 94/3; P802-809. March 2026. /episode/index/show/psoundbytes/id/41686940

Ep. 278 "GLP-1 & GIP Therapies: What They Mean for Psoriasis and Psoriatic Arthritis" 06/02/2026

Ep. 278 "GLP-1 & GIP Therapies: What They Mean for Psoriasis and Psoriatic Arthritis" Description: How do GLP-1 receptor agonists or GIP agonists work and what is the impact for my psoriatic disease? Hear dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber answer such questions and more. Join host Archie Franklin as he takes a deep dive into the use of GLP-1 receptor agonists and GIP agonists and the convergence of systemic inflammation related to psoriatic disease with renowned dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and, cardio-immunologist Dr. Brittany Weber, Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. Learn more about the use of incretin hormones, the impact of weight management on psoriatic disease, metabolic and cardiovascular risk, as well as results from the TOGETHER-Pso and TOGETHER-PsA clinical trials. This episode addresses the actions of incretin hormones (GLP-1 receptor agonist and GIP agonist) and how such use may be beneficial in the management of inflammation related to psoriasis and psoriatic arthritis. Thank you to Lilly for their support of this program activity. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber. (1:35) What are incretin hormones and how GLP-1 or GIP receptor agonists (RA) inhibit appetite to initiate weight loss. (3:29) Why GLP-1 RAs are of interest in the management of psoriasis and psoriatic arthritis. (5:23) The metabolic, cardiovascular, and psoriatic disease convergence. (7:19) Will reduction of inflammation impact cardiovascular risk? (10:59) Treatment challenges associated with having psoriatic disease and being overweight or obese. (13:45) Key points around the use of GLP-1 receptor agonists when managing psoriasis and psoriatic arthritis. (17:06) Results of the TOGETHER-PsO and TOGETHER-PsA phase 3 clinical trials combining use of an IL-17 inhibitor and a GIP and GLP-1 receptor agonist therapy. (19:07) Having the conversation of adding a GLP-1 RA medication to a treatment regimen. (22:40) The paradigm shift of GLP-1 receptor agonists and the impact they can have on shared inflammatory pathways. Key Takeaways: · Glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP) agonists are two incretin hormones that assist in managing excess body weight -- which as a result can be helpful in managing inflammation in the body. · Psoriasis isn’t just a skin and joint disease. It’s a complex network of systemic inflammation with shared inflammatory pathways that worsens with increased weight impacting the severity of the disease, and accelerates the risk of metabolic dysfunction, and cardiovascular disease. · The best outcomes occur as a result of multidisciplinary collaboration to address the impact of excess weight and systemic inflammation. If you are struggling to lose weight with diet and exercise, speak with your medical team about your options including the use of GLP-1 or GIP agonists. Guest Bios: Renowned dermatologist Ronald Prussick, M.D., Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland, specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health, first becoming interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta’s work in vascular inflammation trials using FDG-PET/CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick has since participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis and more recently the position statement “GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board”. Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and education oversight to the organization and its Executive leaders. Brittany Weber, M.D., Ph.D. is a cardio-immunologist who is the Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. She is also a member of the Division of Cardiology, a clinical investigator, and imaging specialist. Dr. Weber’s research integrates advanced imaging, molecular biology, clinical trials, and population health to understand how systemic inflammation and immune deregulation drives cardiovascular dysfunction. Prior to joining UT Southwestern in 2025, Dr. Weber served on the faculty at Harvard Medical School and was the Director of the Cardio-Rheumatology Clinic at Brigham and Women’s Hospital, a nationally recognized clinic addressing inflammation-related heart disease through collaborative, patient centered care. Dr. Weber is also an author on the position statement “GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board”. Resources: podcast episode with dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan Press Release podcast episode featuring dermatologist Dr. Erin Boh, patient advocate Brian Lehrschal, and moderator Jennifer Bomberger. /episode/index/show/psoundbytes/id/41505190

Ep.277 "Progress Towards Identifying a Psoriatic Arthritis Diagnostic Test" 05/19/2026

Ep.277 "Progress Towards Identifying a Psoriatic Arthritis Diagnostic Test" Description: “When joint pain is present, the diagnosis of psoriatic arthritis needs to be made as soon as possible, ideally within six months to limit joint inflammation” Dr. Vinod Chandran mentions as he discusses efforts to identify a diagnostic test for those at risk of developing psoriatic arthritis. Join host Jeff Brown as he speaks with leading rheumatologist and clinician scientist Dr. Vinod Chandran, Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto to learn more about the progress and promising results towards developing a psoriatic arthritis diagnostic test through multi-omic assays and identifying the distinct differences between psoriasis and psoriatic arthritis. This episode provides an update on the progress to date of the NPF PsA Diagnostic Test grant initiative which has shown promising results with a potential test entering prospective study in multiple sites soon. Thank you to Johnson and Johnson for their support of this program activity. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome rheumatologist Dr. Vinod Chandran. (0:52) It is challenging to diagnose psoriatic arthritis with many factors leading to a delay in diagnosis. (4:56) The start of Dr. Chandran’s involvement with the PsA Diagnostic Test Grant project. (7:55) The different types of omics and the definition of multi-omic. (9:57) How the multi-omic approach is used to find biomarkers relative to a specific disease pattern. (11:08) Development of a predictive or prevention-based test using gene expression. (13:46) First year results identify 200 markers across different omic approaches that distinguish psoriatic arthritis from psoriasis. (14:58) The significance of MRNA vs mIcroRNA’s use in development of a diagnostic test and how critical that is to dissemination of a potential test. (17:08) Identifying the skin-joint axis in relation to different types of arthritis. (20:20) Next steps to moving the diagnostic test research forward as a prospective study in multiple sites and the cost effectiveness of delivering the test. (23:13) If you have psoriasis, musculoskeletal, back, and joint pain think of psoriatic arthritis and be diagnosed early to maintain a good quality of life. Key Takeaways: · Given challenges associated with diagnosing psoriatic arthritis and the impact on quality of life, in 2019 NPF launched the PsA Diagnostic Test Grant project with the goal of developing an early stage test that would identify and diagnose those with psoriatic arthritis before debilitating joint damage begins. · Progress towards a PsA Diagnostic Test includes the study of multi-omic data sets where 200 distinct biomarkers have been identified leading to a greater understanding of the different pathways between psoriatic arthritis, psoriasis, and the skin joint axis. · A potential diagnostic test is now moving towards the prospective study phase. Until the test is available and if joint pain is present and you have psoriasis, ask your health care provider if it could be psoriatic arthritis and treat appropriately. Guest Bio: Vinod Chandran, MBBS, MD, DM, PhD is a rheumatologist, clinician scientist, and Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto where he is also a Professor of Medicine. His specialties include internal medicine, immunology, rheumatology, and genetic epidemiology. His research focus is on the development of biomarker-based strategies to improve early diagnosis and prognosis of psoriasis and psoriatic arthritis, identification of new treatment targets especially for those who do not respond to current therapies, and strategies to reduce the impact of disease. Dr. Chandran is a Co-Vice President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis or GRAPPA. He is an active collaborator in a multi-center research consortia such as the International Psoriasis and Arthritis Research Team and the Spondyloarthritis Research Consortium of Canada. Dr. Chandran is the recipient of research funding from the National Psoriasis Foundation for his work in identifying a “Multi-omic Diagnostic Test for PsA in Psoriasis Patients”. Resources: “” Advance Online. February 18, 2026. “” Psoriasis Uncovered podcast episode with physiatrist Dr. Erin Maslowski, LB Herbert who lives with psoriatic disease, and moderator Susan McClelland-Tobert, a retired pediatric cardiologist who also lives with psoriatic disease. Glossary of terms: mRNA: Messenger RNA carries protein information or instructions from the DNA in a cell’s nucleus to the cell’s interior where the sequence is read and translated into corresponding amino acids for growing protein chains. Micro-RNA (miRNA): Micro-RNA act as the regulator. They are short and bind to specific target mRNA’s to degrade or inhibit production of protein. /episode/index/show/psoundbytes/id/41345975

Ep.276 "The Metabolic Collision and How You Can Take Control with Psoriatic Disease" 05/05/2026

Ep.276 "The Metabolic Collision and How You Can Take Control with Psoriatic Disease" Description: “What is metabolic disease and why do I have it on top of psoriatic disease?” Hear dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan explore this collision of diseases and how you can take control to help reduce the impact of inflammation. Join host Corinne Rutkowski as she discusses why metabolic disease occurs with psoriasis and psoriatic arthritis and what can be done to improve overall health with dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and Danielle Cahalan, a registered dietitian and coach with All Access Dietitians. Listen as they also discuss the four pillars of health, the latest evidence around use of the Mediterranean Diet with psoriatic disease, key nutrients that impact overall health from omega 3’s, polyphenols, and fiber, to making small sustainable changes. This episode offers information to help explain the connection between metabolic and psoriatic disease and what can be done to decrease health risks associated with both diseases through sustainable changes. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and registered dietitiand and coach Danielle Cahalan. (1:27) Definition of metabolic disease and why the risk is higher among those with psoriasis or psoriatic arthritis. (3:11) How this bi-directional relationship impacts the management of psoriasis and psoriatic arthritis. (6:54) The four pillars of health that can be used to reduce the risk of metabolic disease. (11:17) Does an anti-inflammatory diet exist? (13:46) What is the Mediterranean diet and the foods that are typically included. (16:32) The impact of the Mediterranean diet on systemic inflammation, metabolic health, and severity of psoriatic disease. (21:03) The three types of healthy fats – what they are, how they work, and where to find them. (24:50) The high polyphenol Mediterranean diet from what that means to choosing nutrient dense, colorful foods. (28:04) The koebnerization of the gut microbiome and the impact of the Mediterranean diet and high fiber. (30:59) The DASH diet in combination with the Mediterranean diet lowers oxidative stress and inflammation. (33:14) Sustainability of the Mediterranean diet and flexing behavioral health changes long term. (37:43) Start with small habit changes and then build from there to have an impact on your metabolic health. Key Takeaways: · Research shows a bi-directional relationship between psoriasis and excess body weight leading to increasing severity of disease, decrease in treatment effectiveness, and the development of metabolic syndrome, a group of conditions which together raise the risk of coronary heart disease, stroke, and diabetes. · What you choose to eat can make an impact in managing inflammatory markers, metabolic health to increase insulin sensitivity, decrease high blood pressure, improve lipids and the gut microbiome, as well as support neuro protection and decrease cognitive decline. · Create small sustainable habits that make positive changes to your immune system and gradually work towards building a foundation that benefits your overall health. Guest Bios: Renowned dermatologist Ronald Prussick, M.D. is the Medical Director of the in Rockville and Fredrick, Maryland where he specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails with the latest technology and products. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health. He first became interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta’s work in vascular inflammation trials using FDG-PET?CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick also participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the NPF, which offered a review of studies addressing the impact of dietary interventions in people with psoriasis and psoriatic arthritis. Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and provides education oversight to the organization and its Executive leaders. Danielle Cahalan, MS, RDN is a licensed and registered dietitian and coach with which offers virtual nutrition support services in AZ, CA, CO, CT, FL, IL, IN, MA, MO, MT, NJ, NY, NC, OR, PA, SC, TX, VA, WA, WI, and WY. All Access Dietitians infuses the science of motivation, habit formation, and sustainable behavior change into every session that addresses weight management and metabolic health, to women’s health and digestive support. Danielle’s primary focus during sessions is to help her clients find that intersection between enjoyment and satisfaction with their food choices that also support their health through sustenance. It’s about finding that balance between feeling empowered, energized, and confident in the ability to make decisions that impact health, wellness, and longevity. Resources: “” © 2009 Oldways Preservation and Exchange Trust and UCSF Weill Institute for Neurosciences Memory and Aging Center. (Dietary Approaches to Stop Hypertension). February 25, 2026. NIH (National Heart, Lung, and Blood Institute) AMA Dermatology . Dec. 1, 2025 Journal of Psoriasis and Psoriatic Arthritis 2024 Jan 9. /episode/index/show/psoundbytes/id/41151265

Ep. 275 "Tips for Managing Psoriasis When Life Takes You Out of Your Routine" 04/23/2026

Ep. 275 "Tips for Managing Psoriasis When Life Takes You Out of Your Routine" Description: Coping with psoriasis can be challenging when your routine changes. Hear NPF Youth Ambassadors Aditi, Alyssa, and Pierce offer what they do to overcome such challenges when out of their routine. Join host Kaleigh Welch as she discusses tips for coping with changes that occur when traveling to visit family or friends, going on vacation, camping, or a change in schedule with three amazing NPF Youth Ambassadors Aditi, Alyssa, and Pierce who live with psoriasis. Hear their story from challenges with their initial diagnosis, struggles with insecurities, whether they choose to inform others, and what they do to manage their disease and stress while living their life with confidence to pursue their chosen activities no matter if their routine changes. This episode features how 3 NPF Youth Ambassadors overcome challenges when out of their routine and how they respond while managing their psoriasis. (0:00) Intro to Psoriasis Uncovered & welcome to guests Youth Ambassadors Aditi, Alyssa, and Pierce. (0:55) Overcoming challenges from diagnosis, finding the right treatment, to making choices impacted by living with psoriasis. (5:44) Tips for what to do and pack when traveling for activities that disrupt the usual routine. (10:11) Keeping the skin moisturized can be a challenge but find a routine and product that works. (12:38) Preparing for potential triggers that could initiate the Koebner phenomenon and psoriasis. (13:33) Managing the impact of stress when out of the routine or traveling. (16:20) Alyssa’s approach to managing fatigue. (16:53) The impact of diet and exercise when managing psoriasis. (18:47) Telling others about psoriasis when staying at a friend’s house or hotel. (23:36) Our number one recommendation for when being out of your routine. (25:39) Be confident about who you are and trust you’ll find the right treatment and routine for your psoriasis. Key Takeaways: · Being out of your normal routine whether traveling on vacation or for work, camping, staying at a hotel or with family or friends can present challenges to managing your psoriasis. · Preparing in advance by anticipating medication or over-the-counter needs, telling others, and asking for help can reduce the impact of challenges due to a change in routine. · Be confident about who you are, find a treatment that works, and learn to live successfully with your psoriasis. Guest Bios: Aditi enjoys Carnatic singing, violin, figure skating, and participating in Model UN where students debate global issues, learn diplomacy, international relations, and public speaking. Aditi was diagnosed with psoriasis at 10 years old and has used topicals to manage her disease along with diet, exercise and stress management. Prior to becoming a Youth Ambassador she had never met anyone with psoriasis. She plans to pursue a career in dermatology. Alyssa is relatively new to the NPF Youth Ambassador program, joining in 2025 to connect with others who also live with psoriasis. Her diagnosis process was challenging and eventually she was diagnosed with guttate psoriasis after being improperly diagnosed and given treatments that didn’t fully clear her psoriasis. This experience changed her life both physically and emotionally. Alyssa is a busy student-athlete serving as a member of her school’s varsity cheer team and being a star pitcher for her school’s softball team. Pierce connected with NPF right after being diagnosed with moderate to severe plaque psoriasis in 2024 which covered over half of his body. Together with his mother they learned more about the disease and management with various treatment options from NPF, quickly learning what worked and what didn’t. Per Pierce “it was horrible dealing with it for a while because I couldn’t hide the plaques.” After facing challenges with step therapy and eventually traveling to the Mayo Clinic he found the treatment he needed to help clear his skin. Pierce is very active in golf playing at least 5 days a week. He currently plays for his high school team, the Louisiana Junior Golf Tour, and the American Junior Golf Association (AJGA). Pierce also became a Youth Ambassador to meet others with psoriatic disease. Resources: -Meet other teens who have psoriatic disease. -“” podcast episode. -“” Advance Online. June 11, 2025. /episode/index/show/psoundbytes/id/40987330

Ep. 274 "Finding Connections Made Us Stronger with the National Psoriasis Foundation" 04/07/2026

Ep. 274 "Finding Connections Made Us Stronger with the National Psoriasis Foundation" After being diagnosed with psoriasis and psoriatic arthritis, finding a community that understood how life changed meant everything to Jody Quinn, Ben and Kathryn Rifenbark. Join host Alan Simmons as he addresses life with psoriasis and psoriatic arthritis before and after finding the National Psoriasis Foundation with 3 amazing volunteers – Jody Quinn, Ben and Kathryn Rifenbark. Hear their story from struggles with initial diagnosis, being an advocate for their own health care, to how they chose to become part of a community and help others with the disease to support the mission of the National Psoriasis Foundation. Being part of NPF truly changed their lives! This episode features how 3 volunteers changed their lives to navigate the challenges of being diagnosed with psoriatic disease to taking steps to help others in need and the mission of the National Psoriasis Foundation. Timestamps: · (0:00) Intro to Psoriasis Uncovered & guest welcome Jody Quinn, Ben and Kathryn Rifenbark. · (0:59) What life was like for Ben and Kathryn from diagnosis to finding a community through NPF. · (2:42) Facing psoriatic arthritis first and being undiagnosed for years was challenging for Jody. · (4:48) Finding control over psoriatic disease by becoming an advocate for change. · (6:15) Diving into the deep end to help fundraising efforts. · (7:03) Becoming a One to One mentor to help answer questions from others and share the positive impact NPF makes in our lives. · (8:52) Making connections to help raise awareness about psoriatic disease from resolutions to public service announcements and lighting bridges in NPF’s colors -- orange and blue. · (10:40) Receiving the NPF Volunteer Innovator award and being a Psoriatic Ambassador Honoree. · (12:04) Benefits we received from attending the IMPACT Summit Volunteer Leadership Conference. · (15:11) Jody’s single most life-changing event was attending the FDA Drug Development meeting. · (17:23) It’s important to advocate for your own health care needs while continuing to learn from others and resources available through the NPF. · (19:14) Every step no matter how small or large makes an impact and is important. Key Takeaways: · Being diagnosed with psoriasis and psoriatic arthritis is a life-long journey which can be made easier by finding the right health care, education and resources, as well as a community that understands what it means to live with psoriatic disease. You are not alone. · You can take control over your disease by advocating for policy changes that affect all patients regardless of what chronic disease they may have. Let your voice be heard. · Every step you take no matter how small or large makes a difference – whether it’s learning more about psoriatic disease, sharing your story, or participating as a volunteer. You can make an impact. Start your journey with NPF today! Guest Bios: Jody Quinn has a long history of involvement with NPF as a volunteer. She first became a volunteer in 2012 after seeking to connect with others who have psoriatic disease during a Walk event. She remembers meeting an inspirational group of volunteers. Wanting to learn more about her disease she attended More Than Skin Deep and Be Joint Smart events and served as a moderator. Continuing her path of involvement she attended Volunteer Conferences in Chicago and San Francisco. In 2016 she attended her first Capitol Hill Day followed by the FDA Patient Focused Drug Development (PFDD) meeting. Her involvement was so profound she remains an active advocate promoting research and legislation to enhance access to treatments and health care services. Jody has been so successful in promoting awareness about psoriatic disease, she was awarded the NPF Volunteer Innovator Award in 2017. In 2025 she was also named as the New England Soiree Psoriatic Ambassador Honoree for her impactful service and tireless advocacy. In her words, “I volunteer because it gives me some control over what often feels like a completely uncontrollable disease. It allows me to have a say in what is happening with my life and my disease, which I didn't have before. I also volunteer so that others don't have to go through the same long and difficult journey to diagnosis and treatment that I did." Kathryn & Ben Rifenbark discovered the NPF after many challenges with finding the right diagnosis for Ben’s psoriasis. Through a local NPF Take ACTION event Ben quickly learned he wasn’t alone in living with his disease, while Mom, Kathryn, gained as much information as she could. After the event, they soon became part of the NPF community with Ben serving as the 2024 Take ACTION Ambassador and a leading peer-to-peer fundraiser. He shared his story and a motivational message at last year’s Take ACTION event to help encourage others to support the mission of the NPF. Ben is also an IMPACT Ambassador learning how to advocate for himself and has participated in the IMPACT Summit representing the amazing youth who are part of our NPF Community. Kathryn is now a mentor sharing what she’s learned with other parents. Resources: May 1, 2025 Advance Online December 11, 2025. (Ben & Kathryn Rifenbark) Advance Online Updated September 29, 2025. /episode/index/show/psoundbytes/id/40750785

Ep. 273 "Moderate to Severe Plaque Psoriasis in Children and in Adults with High-Impact Site Involvement" 04/02/2026

Ep. 273 "Moderate to Severe Plaque Psoriasis in Children and in Adults with High-Impact Site Involvement" Description: Learn why advocating for care is crucial when moderate to severe plaque psoriasis develops at a young age or in high-impact sites, and how advanced biologic therapies can offer effective solutions for those that may be undertreated. Join moderator Kaitlin Walden, patient advocate Carolyn, and dermatologist Dr Candrice Heath as they discuss the realities of living with moderate to severe plaque psoriasis at a young age, as well as adult patients with plaque psoriasis in high-impact sites, like the scalp, nails, and face. Carolyn shares her personal journey with moderate to severe plaque psoriasis and how it has continued from childhood into adulthood, while Dr Heath offers insights to help caregivers and patients navigate treatment approaches, including when and how a biologic therapy may be helpful. This episode addresses challenges associated with living and treating moderate to severe plaque psoriasis in children and adults. This episode is sponsored by Johnson & Johnson. Please see and full for the product mentioned in this episode. Timestamps: · (0:23) Intro to Psoriasis Uncovered and guest introductions from dermatologist Dr. Candrice Heath and Carolyn, a patient advocate living with plaque psoriasis and psoriatic arthritis. · (1:22) Information about, and pivotal data for, TREMFYA® (guselkumab), a biologic used to treat adults and children 6 years and older who weigh at least 88 lbs or 40 kilograms with moderate to severe plaque psoriasis. · (3:48) Living with psoriasis as a child can be difficult with challenges in being diagnosed correctly and receiving appropriate treatment. · (6:17) A dermatologist’s view of children and adolescents living with plaque psoriasis including in high-impact sites. · (8:14) It’s important to advocate for yourself and the best possible care. · (9:37) Open communication with your dermatologist helps identify the best possible treatment plan, which is dependent on several factors including the availability of new treatment options. · (12:05) Carolyn’s biggest challenge is managing her psoriasis and then psoriatic arthritis. · (14:20) Results of the SPECTREM clinical trial addressing treatment of adults with moderate plaque psoriasis in high-impact sites. · (17:38) Find the support and information you need to find the right treatment. · (21:48) Important Safety Information about TREMFYA® (guselkumab). Key Takeaways: · Plaque psoriasis can be challenging both physically and emotionally for children and adults – especially when high-impact site involvement (such as the face, scalp, armpits, and groin) is present. · Individual treatment plans vary and are based on several factors, including the severity of psoriasis, dosing schedule, cost, or route of administration. Finding the right treatment for plaque psoriasis is a collaboration between a dermatologist, the patient, and/or family (should the patient be a child). · A number of medicines that treat plaque psoriasis from the inside out, including biologics, are now available for children and adults. Such treatment options are continuing to expand. Guest Bios: Candrice Heath, M.D. is a highly respected triple board-certified dermatologist who sees both children and adults at Howard University Hospital in Washington DC where she is also an Associate Professor in the Department of Dermatology. She is board-certified in dermatology, pediatrics, and pediatric dermatology. Dr Heath is a nationally recognized speaker, pediatric and adult dermatology clinical researcher, and has held a variety of leadership roles including Chair for the Pediatric Dermatology Research Alliance (PeDRA), Skin of Color and Pigmentary Disorders Focused Group, Skin of Color Society National Secretary-Treasurer, and American Academy of Dermatology Diversity Committee member. Her clinical, research, and teaching interests are shaped by insights gained from her unique practice filled with both children and adults in addition to her passion for exploring the intersection of dermatology and social science. Carolyn Pugh is a patient advocate and volunteer with the National Psoriasis Foundation who lives with psoriasis and psoriatic arthritis. Carolyn was diagnosed with psoriasis at age 11 after being misdiagnosed and offered treatments that didn’t work. Once she was diagnosed with plaque psoriasis some of the initial treatments were difficult and unsustainable. Over the years she has learned to advocate for her own self-care and feels her personal experiences can help empower other adults and parents. Resources: · about treatment options for children and adolescents at Our Spot for Youth and Parents · about psoriasis in high-impact sites /episode/index/show/psoundbytes/id/40702985

Ep. 272 "Insights on the Use of Biosimilars for Psoriatic Disease" 03/12/2026

Ep. 272 "Insights on the Use of Biosimilars for Psoriatic Disease" Hear leading dermatologist Dr. E. James Song and patient advocate Ana Rinck share their perspectives on the use of biosimilars to manage psoriasis and psoriatic arthritis. The use of biosimilars is growing with 24 currently on the market and more on the way for the treatment of psoriasis and psoriatic arthritis. What does this mean for you? Find out as we explore the use of biosimilars, the impact of interchangeability, what it’s like switching to a biosimilar, and what questions to ask your health care provider with leading dermatologist and NPF Medical Board member Dr. E. James Song, Director of Clinical Research at Frontier Dermatology Partners, and patient advocate Ana Rinck who currently uses a biosimilar to treat her psoriasis and psoriatic arthritis. The intent of this episode is to offer an update on the use of biosimilars and to hear the experience of those who have used biosimilars to manage psoriatic disease. This episode is sponsored by . Timestamps: (0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. E. James Song, Director of Clinical Research and Co-Chief Medical Officer, Frontier Dermatology, and patient advocate Ana Rinck, who presents her experience with using a biosimilar to treat psoriasis and psoriatic arthritis. (0:58) Definition of what is a biosimilar in comparison to a biologic which is also referred to as the original bio-originator or reference product. (3:10) What biosimilars are available and how they are used. (4:35) The term interchangeable and what it means for use of a biosimilar. (5:46) Ana’s diagnosis to treatment options starting with use of topicals to ultimately use of a biosimilar. (7:57) Treatment discussion and choices when faced with diminishing effectiveness within a class of medications. Should a biosimilar be considered as an option? (9:50) Questions to consider when there’s a change in treatment. (10:57) FDA announcement to simplify the development process for biosimilars and what that means for the future use of biosimilars. (13:55) What to consider when thinking of a biosimilar as a treatment option and where to find help when needed. (14:53) The hope and equity of access that biosimilars represent is here for the appropriate individual. Key Takeaways: · A biosimilar is an FDA-approved biologic product that behaves and functions like a brand biologic treatment which is also called the reference product or bio-originator. There are no clinically meaningful differences between biosimilars and their reference product. · The FDA has approved several biosimilars for the treatment of psoriasis and psoriatic arthritis. Some have been identified as interchangeable which means a biosimilar could be substituted for a reference product without a health care provider’s approval pending state legislative rules. · Don’t be afraid to ask questions or access resources to assist with preparing for a medication change should that change be initiated either by yourself, your healthcare provider, or your health insurance company. Guest Bios: E. James Song, M.D. is a nationally recognized dermatologist and clinical researcher who is also a Clinical Instructor at the University of Washington. Dr Song is recognized as a key opinion leader in treating psoriasis and atopic dermatitis. He is actively involved in the development of new therapies for dermatologic disease and has firsthand experience with treatments before they come to market. Dr. Song has been published extensively in peer review journals and regularly participates in meetings both as a lecturer and attendee. He is also a Medical Board member of the National Psoriasis Foundation. He believes that the best health outcomes come from shared decision making between the patient and physician. Dr. Song strives to help patients understand not only their condition, but all their treatment options. Ana Rinck is a patient advocate and volunteer for the National Psoriasis Foundation. She developed psoriasis in 2009 following symptoms she noticed for a few years which proved to be challenging to diagnose. She managed for many years on topicals and intralesional injections. In 2018 she was diagnosed with psoriatic arthritis and started use of a biologic realizing she needed to protect her joints from further damage. She now uses a biosimilar to manage her psoriatic disease. Ana owns her own private consulting business and is an Operations and Project Manager. Resources: - about biosimilars, interchangeability, and state substitution rules. -Armstrong A, Callis Duffin K, Feldman S, Glick B, Kalb R, Reddy S, Schwartzman S, Yamauchi P, Calabrese C, Cordoro K, Desai S, Gladman D, Han G, Hawkes JE, Hsu S, Kircik L, Koo J, Kreuger GG, Lebwohl M, Leonardi C, Lewitt GM, Liao W, Liu C, Markenson J, Merola JF, Orbai A, Prussick R, Richardson V, Soung J, Van Voorhees AS, Wallace E, Weinberg J, Wine Lee L, Harris J, Koons S, Howard L. . National Psoriasis Foundation Medical Board. 2023. -If you need help finding a dermatologist near you contact the for assistance. /episode/index/show/psoundbytes/id/40400015

Ep. 271 "Hope and Healing: Treating Nail Psoriasis" 02/17/2026

Ep. 271 "Hope and Healing: Treating Nail Psoriasis" Description: Nail psoriasis is tough to treat. Hear Rebecca, a patient who lives with nail psoriasis, and dermatologist Dr. Paul Yamauchi discuss the diagnosis, care, and treatment for this high-impact site. Join host Roy Pankey as he addresses the complexities of nail psoriasis from diagnosis to coping and the latest research and treatments with leading dermatologist, Dr. Paul Yamauchi from the Dermatology Institute and Skin Care Center and Clinical Science Institute, and Rebecca, a patient advocate with the National Psoriasis Foundation who lives with nail psoriasis. Listen as they discuss the challenges associated with living with nail psoriasis, and what can be done to help manage the disease from self-care to treatment choices – including the latest research developments. While nail psoriasis can be challenging to diagnose and treat, there are many actions that can be taken to help minimize the impact of this disease. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome Rebecca and dermatologist Dr. Paul Yamauchi. (0:58) Signs or changes to nails that indicate nail psoriasis is present. (2:07) Elements and challenges to diagnosing nail psoriasis. (4:41) What is a nail biopsy and how is it done. (5:25) How nail psoriasis relates to psoriatic arthritis. (6:19) What flares my nail psoriasis. (6:57) There are many treatment choices used to treat nail psoriasis based on convenience, impact of disease, preference, and when to expect improvement. (10:13) A personal perspective on medications used to treat nail psoriasis. (10:42) Research results of the latest medications used to treat nail psoriasis. (13:03) Upcoming oral agents that could be effective in treating nail psoriasis. (15:14) Self care tips, use of nail polish and artificial nails. (19:21) Nail psoriasis is challenging to treat. Be patient with yourself and your dermatologist. Key Takeaways: · Nail psoriasis presents many challenges from living and coping with the disease to diagnosis and treatment. · Medication choices for nail psoriasis are based on convenience, impact of disease, and preference for use of topicals, phototherapy, oral agents, and/or biologics. · Since nail psoriasis takes time to see improvement, it is important to be patient with yourself and your dermatologist. Guest Bios: Dermatologist Dr. Paul Yamauchi is President and Medical Director of the Dermatology Institute and Skin Care Center and Clinical Science Institute in Santa Monia, CA. Dr. Yamauchi is a leading expert in the field of psoriasis and has extensive experience treating different types of psoriasis using the latest treatments from topicals to biologics. He is also a Clinical Professor in the Division of Dermatology with David Geffen School of Medicine at UCLA. Dr. Yamauchi has conducted over 200 clinical research trials as principal investigator and is widely regarded as an outstanding clinical research investigator exploring innovative therapies, serving on advisory panels designing protocols that led to FDA approval of various medications. Dr. Yamauchi is a past member of the Medical Board of the National Psoriasis Foundation and is a fellow of the American Academy of Dermatology, and the American Society of Dermatology Surgery. Rebecca Cohen, is a patient advocate, who was diagnosed with plaque, scalp, and nail psoriasis at age 6 after being adopted by a dermatology physician’s assistant who quickly found the best treatment path for her. Prior to that time she was told she had eczema. “My skin actually was really bad as a child. Horrible. Hands, feet, elbows, everything.” Eventually after experiencing joint pain and fatigue, she was also diagnosed with psoriatic arthritis around age 20 at which time she started on her first biologic. “I struggled a lot with nail pitting and thickness as a kid and have recently been going through another episode.” Resources: -Still have questions? Contact the . - Advance Online June 2025. - Advance Online March 2020 . /episode/index/show/psoundbytes/id/40132890

Ep. 270 "Cold Weather, Hot Flares: Winter Survival Tips for Psoriasis and PsA" 01/29/2026

Ep. 270 "Cold Weather, Hot Flares: Winter Survival Tips for Psoriasis and PsA" “Help! It’s winter and my psoriasis and psoriatic arthritis is flaring.” Listen as certified physician assistant Eileen Cheever offers tips to help manage psoriasis and psoriatic arthritis flares that occur during the winter months. Join host Corinne Rutkowski as she explores tips for managing psoriasis and psoriatic arthritis when cold weather flares the disease with Certified Physician Assistant Eileen Cheever from Clearview Dermatology. Listen as they discuss why flares occur and tips for improving flares from humidity, moisturizing products even for palmoplantar psoriasis, types of fabrics to layer, addressing aches and pains with psoriatic arthritis, use of rescue therapy, to stress and mood changes. This episode offers information to help address winter flares that may cause you to struggle with your psoriatic disease during cold weather. Timestamps: (0:00) Intro to Psoriasis Uncovered & guest welcome Certified Physician Assistant Eileen Cheever. (1:15) Definition of a psoriasis or psoriatic arthritis flare. (2:32) How cold weather could be connected to winter flares of psoriatic disease. (4:11) Tips for addressing dryness and lack of humidity in the home. (6:13) Products that help moisturize your skin and when is the best time to apply it to your skin. (8:56) Products for moisturizing the hands and feet with palmoplantar psoriasis. (12:33) Types of fabrics to layer in the winter to help decrease the itch while staying warm. (14:15) Tips for addressing the aches and pains that come with cold winter months. (16:22) Medication changes vs use of rescue therapy for treating a winter flare. (17:51) Tips to help manage overall health, stress, and mood. (21:37) Reach out to your health care provider if you are struggling with your psoriatic disease. Key Takeaways: · While we don’t completely understand the connection, 4 out of 10 people identify winter as the season that flares their psoriasis. · Factors that contribute to cold weather flares include lack of moisture or humidity in the air, viruses or flu, long heated showers that lead to dry, itchy skin, itchy fabrics, stress, and depression with dark days. · Strategies to address winter flares include various moisturizing products, maintaining 60% humidity, choosing breathable fabrics, lifestyle choices, and keeping your dermatologist and rheumatologist informed should rescue therapy be needed. Guest Bio: Eileen Cheever is a certified dermatology physician assistant (PA-C) with a clinical practice at Clearview Dermatology where she treats adults and children with a variety of diseases of the skin, hair, and scalp including psoriasis. She is a diplomate member of the Society of Dermatology Physician Assistants, a founding advisory board member for Elevate Medical Education, a member of the American Academy of Physician Assistants, and a member of the NPF Advanced Practice Provider (APP) Advisory Committee. She has a passion for providing education and lectures frequently at dermatology conferences across the country. Resources: . National Psoriasis Foundation 2023©. . Advance Weekly. Updated September 30, 2025. podcast episode addressing why pain occurs, its impact, and what can be done to manage pain both physically and emotionally. /episode/index/show/psoundbytes/id/39903420

Ep. #269 "Melodies & Medicine: Navigating Psoriasis with Art Garfunkel" 12/18/2025

Ep. #269 "Melodies & Medicine: Navigating Psoriasis with Art Garfunkel" Description: In this episode hear board-certified dermatologist Dr. Omar Noor and special guest, music icon Art Garfunkel discuss management of and living with moderate to severe plaque psoriasis. Join us for this special episode of Psoriasis Uncovered as music icon Art Garfunkel shares his personal journey with moderate to severe plaque psoriasis. Alongside renowned dermatologist Dr. Omar Noor and moderator Max Blitstein, Art shares insights on his diagnosis, how psoriasis has impacted his musical career, and his experience using the treatment Ilumya (tildrakizumab-asmn). Tune in to explore the intersection of melodies, medicine, and advocacy, and gain inspiration for living with psoriasis. The intent of this episode is to share Art Garfunkel’s story of living an active music career with plaque psoriasis and how he eventually found a treatment that works for him. This episode is sponsored by . For important safety information: Timestamps: (0:23) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. Omar Noor, Co-Owner Rao Dermatology, and special guest, music icon, poet, author and actor Art Garfunkel who lives with plaque psoriasis. 1:04 Psoriasis came quietly into Art’s life but wasn’t easy. 1:36 Art’s life on the road touring and being in the spotlight with psoriasis. 2:50 Having a strong support system is just as important as managing the physical symptoms of psoriasis. 3:59 A personalized approach to treatment options is possible when having an open dialogue with your doctor. You don’t have to face the challenge of living with moderate to severe plaque psoriasis alone. 5:27 What to expect when using Iluyma®, a biologic given 4 times a year. 8:54 Art’s message to anyone newly diagnosed with plaque psoriasis who feels overwhelmed. 9:20 Your treatment plan is a collaborative decision between you and your health care provider and stay informed with reliable evidence-based resources. 10:57 Closing comments and where to learn more information about Iluyma®. 11:39 Important Safety Information about Iluyma®. Key Takeaways: · Living with psoriasis can be a private struggle with challenges to overcome both physically and emotionally but know that you are not alone. · Since no two people are alike and given the variety of available treatment options, tailoring treatment options to the needs of an individual’s lifestyle is possible. · Open communication between you and your health care provider is key to finding the right treatment for you. Guest Bios: Art Garfunkel is a music legend, poet, author and actor who has received numerous awards and honors throughout his life including being inducted into the Rock & Roll Hall of Fame. Internationally recognized for having a distinctive voice as part of the duo Simon & Garfunkel and later Garfunkel & Garfunkel, he inspired many with his melodies and rhythms. But behind the harmonies and stage lights he was struggling to live with the challenge of moderate to severe plaque psoriasis feeling isolated and depressed. Finding the right treatment after years of struggling, Art hopes to inspire others through his story saying “There’s real power in speaking our truths. Vulnerability, as it turns out, is not weakness, it’s connection. And connection is healing. Take a breath. You will find your way through this.” Omar Noor, M.D. is a board-certified dermatologist and co-owner of Rao Dermatology in New York and New Jersey. He started his dermatology career as a partner in his practice with a focus on medical dermatology, having a clinical interest in psoriasis and atopic dermatitis. Dr. Noor has received several awards from the New York Academy of Medicine in the field of dermatology. He currently serves as a member of the Editorial Advisory Board for Dermatology Times and the NYC Medical Reserve Corp. Resources: “”, Read more about Art’s story at Advance Online, National Psoriasis Foundation. August 26, 2025. from types, symptoms, typical locations, to diagnosis and life with psoriasis. /episode/index/show/psoundbytes/id/39446235

Ep. #268 "Beyond the Surface: Rethinking Psoriasis Severity and Elevating the Patient Voice" 12/02/2025

Ep. #268 "Beyond the Surface: Rethinking Psoriasis Severity and Elevating the Patient Voice" Description: Psoriatic disease affects far more than just the skin. Hear leading dermatologist Dr. April Armstrong and Dr. Benoît Guérrette discuss this and more with Jensen, a patient advocate. Psoriatic disease affects not only the skin but it can impact confidence, emotional and social well-being, and daily life. In this episode, join moderator Dr. Guy Eakin, Chief Scientific and Medical Officer at NPF, as we explore the disconnect between clinical classifications of psoriasis and what patients experience in real-life with leading dermatologist Dr. April Armstrong, Dr. Benoît Guérrette, Vice President of Dermatology & Rheumatology at Takeda, and Jensen, a NPF patient advocate and former Lead Youth Ambassador. Listen as we address the need for a more nuanced approach to classifying disease severity that accounts for the holistic needs of psoriatic disease, as well as share insights into how advocacy and awareness can drive change in treatment access and care standards. The intent of this episode is to identify how clinical severity classifications of psoriasis are evolving to meet the needs of those who live with the disease and how that change impacts overall management. This episode is sponsored by . Timestamps: (0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. April Armstrong, Vice President of Takeda, Dr. Benoît Guérette, and patient advocate Jensen, who discuss the unmet needs of people with moderate psoriasis and how as a community we can better serve those living with the disease. 2:22 How health care providers and the biopharmaceutical industry are coming together to address systemic eligibility and the unmet needs of people living with psoriasis. 4:25 Quality of life should be included when assessing clinical severity in psoriasis and identification of appropriate treatment choices. 6:52 The impact of misdiagnosis, inappropriate treatment, and effect on high impact sites can be life- altering. 8:30 How appropriate treatment and knowledge can make all the difference when diagnosed with plaque psoriasis. 9:40 Views on the psoriasis disease classification system and how it’s evolving to include real life impact from physical and emotional needs, to more personalized care for those living with psoriasis, even when small body surface areas are involved. Severity isn’t defined by skin coverage alone. 12:38 What’s needed to prioritize the care and outcomes of people living with psoriasis. 14:18 The future of management and care for psoriatic disease. 15:53 “My skin tells a story.” Wisdom from what I wish I had known previously. 16:52 Moving closer to care that truly reflects the lives and needs of those who live with psoriasis. Key Takeaways: · Severity of psoriasis isn’t defined by skin coverage or body surface area (BSA) alone. The impact on quality of life should also be considered in the assessment, selection of treatment, and management of the disease. · The psoriasis disease classification system is evolving to be more of a patient centered approach. Many clinicians are now using the International Psoriasis Council (IPC) or 2 bucket approach to identify whether someone should receive a topical or systemic treatment based on location and response to treatment, as well as impact on quality of life. · With continued research and development, the next 5 to 10 years could see a shift in effective treatment options while also treating sooner to initiate better outcomes for people living with psoriasis and psoriatic arthritis. Guest Bios: April Armstrong, M.D., M.P.H. is an internationally renowned dermatologist and clinical researcher who is a Professor and Chief of Dermatology at the University of California Los Angeles (UCLA) where she specializes in inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa (HS). Dr. Armstrong is also the Co-Director for Network Resources at the UCLA Clinical and Translational Research Institute. She has conducted over 150 clinical trials and published over 350 high impact articles in scientific journals. Dr. Armstrong holds multiple leadership positions including the immediate Past Chair of the National Psoriasis Foundation Medical Board, Co-President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), councilor for the International Psoriasis Council, and board member for the International Dermatology Outcome Measures and the American Academy of Dermatology. Benoît Guérette, Ph.D. is an accomplished leader in medical affairs with extensive experience across academia and the pharmaceutical industry. Since March 2025, Dr. Guérette has served as Vice President of Dermatology and Rheumatology US Medical Affairs at Takeda Pharmaceutical. Prior to joining Takeda, he held several strategic and leadership roles at various pharmaceutical companies, including overseeing clinical development, global and U.S. medical affairs, global access & pricing, translational sciences and more. Before transitioning to the industry, Dr. Guérette was an Associate Professor of Immunology at Laval University, leading research in cancer immunology. He holds a Ph.D. in Medicine, Microbiology, and Immunology from Laval University and completed postdoctoral studies in Inflammation and Immunology at Harvard Medical School. Jensen is a volunteer and former Lead Youth Ambassador for the National Psoriasis Foundation. Jensen developed psoriasis at age 7 but wasn’t formally diagnosed until age 14 being misdiagnosed along the way, trying different management approaches that were ineffective. She was a competitive swimmer from elementary through high school and in the last 2 years of high school played lacrosse. Upon finishing high school she attended college becoming a registered nurse in an intensive care unit. Jensen wants “youth living with psoriatic disease to feel a community that is behind them and with them every step of the way. I really want to be able to make a difference in a way that would’ve helped me as a child when I was diagnosed.” Resources: Ø “Reassessing Psoriasis Severity” Advance Online, National Psoriasis Foundation. H. Onorati. January 16, 2024, Ø “Psoriasis Involving Special Areas is Associated with Worse Quality of Life, Depression, and Limitations in the Ability to Participate in Social Roles and Activities”. Blauvelt, A., Strober, B., Gondo, G., Journal of Psoriasis and Psoriatic Arthritis Volume 8, Issue 3. /episode/index/show/psoundbytes/id/39224935

Ep. 267 "Managing Chronic Pain with Psoriatic Arthritis" 11/20/2025

Ep. 267 "Managing Chronic Pain with Psoriatic Arthritis" Description: Chronic pain can be difficult to live with. If you have psoriatic arthritis you know all too well what that means. Listen as physiatrist Dr. Erin Maslowski and LB Herbert offer ways to manage pain before it manages your life. Join host Susan McClelland-Tobert, a retired pediatric cardiologist who also lives with psoriatic disease as she uncovers the topic of what is chronic pain and how to manage it with Dr. Erin Maslowski, a physiatrist at Emplify Health System who specializes in physical medicine, rehabilitation and pain management, along with LB Herbert who also lives with psoriasis and psoriatic arthritis, and knows all too well what it means to live with pain, developing her own pain tool kit. Hear different strategies for managing initial flares to when pain escalates. Pain doesn’t have to dictate how you live your life. This episode addresses why pain occurs, it’s impact, and what can be done to manage pain both physically and emotionally. Timestamps: (0:23) Intro to Psoriasis Uncovered & guests physiatrist Dr. Erin Maslowski and LB Herbert (1:48) The unpredictability of pain and what pain means to LB. (2:31) The science behind what happens in the body when acute and chronic pain occurs. (5:08) General principles and first steps to managing pain associated with inflammatory arthritis. (11:00) Recognition of flares and taking action to reduce the impact before pain escalates. . (14:02) Steps to address the chronic pain cycle as it escalates such as steroid injections and medications that change how the brain perceives pain signals. (20:54) Side effects and cautions for use of pain management medications. (24:17) What and who LB turns to for managing her pain. (25:50) Support resources and who to consider as part of a pain management team. (33:16) Overcoming the stigma of mental health and “it’s all in your head”. (34:45) Addressing the challenge of fatigue that often comes with pain. It’s more than feeling tired. (39:32) Activities to keep the body moving to help avoid stiff joints. . (42:11) What’s on the horizon for managing pain. (44:55) Start small, experiment with change, but above all give yourself grace if you’re not able to do something. Gain what control you can to live your life your way. Key Takeaways: · Chronic pain (existing for more than 3 months) occurs when ongoing inflammation keeps signaling pain via the nervous system becoming hypersensitized and greater than the original pain signal. This can occur even when inflammation is managed and in control. · Treating chronic pain is complicated however there are many different avenues to help minimize pain associated with inflammatory diseases such as psoriatic arthritis. · Management of chronic pain involves a variety of specialists and support to help address the physical and emotional impact of living with chronic pain. Guest Bios: Dr. Erin Maslowski is a board-certified physician, physiatrist, at Emplify Health System where she specializes in Physical Medicine, Rehabilitation, and Orthopedic Sports Medicine providing care for musculoskeletal and spine injuries and pain management including image-guided injection procedures. She has expertise in treating arthritis, spinal stenosis and spondylosis, rotator cuff injury, and other conditions with the ultimate goal of restoring function after injury to the muscle, bone, soft tissue, or nervous system. Dr. Maslowski is a Clinical Assistant Professor at the University of Wisconsin School of Medicine and Public Health where she teaches both medical students and residents. She has over 15 years of clinical experience in physical medicine and rehabilitation. LB Herbert, has been living with the challenge of managing pain associated with psoriatic arthritis for 16 years, even developing her own tool kit through the years. She has shared what’s she’s learned on other episodes of this podcast, through articles, and as a One-to-One Program mentor for the National Psoriasis Foundation. LB began her journey in 2009 with back pain. Following many years of being misdiagnosed she finally found a rheumatologist who put all her symptoms together to diagnose her with psoriatic arthritis and place her on an appropriate treatment path. She states “my biggest challenge is not knowing what each day will bring, what the symptoms will be, and if I wake up and flare. It’s a continuous unknown.” Resources: Podcast episode: with rheumatologist Dr. Philip Mease, Dr. Ernest Choy, from Cardiff University School of Medicine, with patients Melissa Leeolou and Minionette “Mini” Wilson who discuss causes, symptoms, risks, and tips for managing chronic pain and fatigue successfully. /episode/index/show/psoundbytes/id/39104825

Ep. 266 "No Compromise: Skin, Joints, and You" 10/30/2025

Ep. 266 "No Compromise: Skin, Joints, and You" Description: In this episode, we’ll explore what it means to aim for no compromise in psoriatic arthritis care—addressing both skin and joint symptoms with dermatologist and rheumatologist Dr. Saakshi Khattri and patient advocate Dayna Pham who lives with psoriasis and psoriatic arthritis. Join moderator Jeff Brown as he asks how patients and their healthcare providers can work in partnership to create a comprehensive, personalized treatment plan that reflects the full impact of psoriatic disease with triple board-certified dermatologist, rheumatologist, and internist Dr Saakshi Khattri, who is also an NPF medical board member, along with Dayna Pham, a patient advocate and volunteer with NPF's advocacy and community engagement teams who is living with psoriasis and psoriatic arthritis. . Whether you're newly diagnosed or navigating long-term care, this conversation is all about advocating for care that supports your whole self—without settling for less. The intent of this episode is to emphasize the need to be aware of psoriatic arthritis symptoms and once symptoms are present accept no compromise when treating skin and joints to obtain clear skin and painless joints. This podcast episode is sponsored by . Timestamps: (0:23) Intro to Psoriasis Uncovered and guest welcome dermatologist, rheumatologist, and internist Dr. Saakshi Khattri and Dayna Pham, a patient advocate and medical student living with plaque psoriasis and psoriatic arthritis. (1:38) Psoriasis is more than skin deep with an inflammatory connection between the skin and joints. (3:03) The onset of psoriatic arthritis can be confusing. Healthy skin and joints should be the expectation without having to compromise on life’s goals. (4:16) Knowing the association between psoriasis and psoriatic arthritis from the beginning is important to avoid delay in diagnosis and treatment. Be aware of systemic symptoms and discuss risks with a health care provider. (6:18 ) The goal of treatment is to achieve meaningful and lasting improvement in skin and joint symptoms. (7:56) Treatments have evolved to target known drivers of inflammation in psoriasis and psoriatic arthritis. (8:29) The IL-17 family is a key cytokine with 6 related signaling molecules. IL-17A and F play a role in the inflammatory process related to psoriasis and psoriatic arthritis. (9:48) What discussion about treatment goals could include between a patient and health care provider. (13:19) If you have psoriasis and psoriatic arthritis you should feel empowered to speak up, seek answers, and find a treatment that offers no compromise on achieving clear skin and healthy joints. Key Takeaways: · Psoriasis is an immune mediated disease that results in systemic inflammation that can affect both the skin and joints. Unfortunately many people do not realize their joint symptoms may be related to their psoriasis. · The purpose of treatment which uses a variety of mechanisms of action targeting specific cytokines such as TNF-alpha, IL-12/23, IL-23, IL-17 is to achieve meaningful and lasting improvement in skin and joint symptoms. · If you have psoriasis and psoriatic arthritis you should feel empowered to speak up, seek answers, and to work with your health care team to identify goals and treatment choices that aim to preserve quality of life. Guest Bios: Saakshi Khattri, M.D., MAS, is a triple board certified medical dermatologist, rheumatologist, and internist in the greater New York area who serves on the medical board of the National Psoriasis Foundation. She is the Director of the Center for Connective Tissue Diseases at Icahn School of Medicine at Mount Sinai. Dr. Khattri’s area of interests include inflammatory and autoimmune skin diseases especially those with a rheumatology/dermatology overlap like psoriasis and psoriatic arthritis. She is actively involved in research and clinical trials for psoriasis and psoriatic arthritis where she seeks to identify immune pathways that lead to new biomarkers and treatments. Dr. Khattri is extensively published in peer reviewed journals and is also a member of the International Psoriasis Council. Dayna Pham is a patient advocate, medical student, and volunteer with NPF's advocacy and community engagement teams who lives with psoriasis and psoriatic arthritis. Dayna’s psoriasis journey began at age 21 when she discovered bumps on her back which became plaques. Within weeks her body was impacted head to toe with plaque psoriasis, at 40% BSA. After being misdiagnosed and undertreated for a few months she eventually found a dermatologist who diagnosed her with moderate-to-severe plaque psoriasis and prescribed a biologic. She’s 25 now and seeks to live her fullest life possible while balancing her psoriasis and psoriatic arthritis. Resources: · from symptoms, diagnosis, treatment options to coping with the disease. Ø · Armstrong A, Levit NA, Schneider B, et al. disease: Results from a US patient survey. J Psoriasis Psoriatic Arthritis. 2025;10(1):1–11. /episode/index/show/psoundbytes/id/38839480

Ep. 265 "Exploring Connections Between Psoriasis and Psoriatic Arthritis" 10/21/2025

Ep. 265 "Exploring Connections Between Psoriasis and Psoriatic Arthritis" Description: Listen as NPF Medical Board Members, dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman discuss the connections between psoriasis and psoriatic arthritis, from cytokines to triggers, current and future treatments. Join moderator Alan Simmons as he gains insights on what connects psoriasis and psoriatic arthritis with leading experts in psoriatic disease and NPF Medical Board members, dermatologist Dr. Robert Kalb with Buffalo Medical Group Dermatology, and rheumatologist Dr. Sergio Schwartzman from Schwartzman Rheumatology, as they discuss the known drivers of psoriasis and psoriatic arthritis, common triggers, benefits of targeted treatments, remission of disease, and upcoming treatment trends. The intent of this episode is to identify potential connections between psoriasis and psoriatic arthritis, and how targeted treatments have changed the outlook for management of psoriatic disease. This episode is sponsored by . Timestamps: (0:41) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman who are both involved in clinical care and research of psoriasis and psoriatic arthritis. (1:15) Current known pro-inflammatory cytokines and cells found in psoriasis and psoriatic arthritis. (5:33) Types of psoriasis that may lead to a higher risk of developing psoriatic arthritis. (9:33) Common triggers for psoriasis and psoriatic arthritis that could cause flares of the disease. (12:59) Key factors that are considered when choosing a treatment plan for any individual with psoriatic arthritis and psoriasis. (18:04) What treatment remission means for psoriasis. (19:36) Use of minimal disease activity (MDA) in psoriatic arthritis and what it means. (22:14) How a better understanding of the disease has led to more effective treatment choices and what choices are used by Dr. Kalb and Dr. Schwartzman for the management of psoriasis and psoriatic arthritis. (28:39) New developments in treatment and research in psoriatic arthritis and psoriasis. (36:01) Given treatment advancements it’s a wonderful time to treat psoriatic disease. 3 Key Takeaways: · Cytokines are chemicals in the body that moderate various processes. In psoriasis and psoriatic arthritis, an unknown trigger stimulates some cells to overproduce pro-inflammatory cytokines such as TNF-alpha, IL-17 or IL-23 leading to the development of skin and joint disease. · Treating psoriasis and psoriatic arthritis helps move the body towards normalizing the over reactive immune system especially with more targeted treatments that safely and effectively block specific cytokines without affecting other organ systems. · Given advancements in targeted treatments the goal is to reach and maintain remission of psoriatic disease. Guest Bios: Leading dermatologist Robert Kalb, M.D. is the Chair of the Buffalo Medical Group Dermatology Department and the Director of the Buffalo Medical Group Phototherapy Center, one of the leading centers for psoriasis care in Western New York. He is also a Clinical Professor of Dermatology at the State University of New York at Buffalo School of Medicine and Biomedical Sciences (SUNY Buffalo), as well as an Adjunct Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania where he plays a significant role in medical education, mentoring both medical students and dermatology residents. Dr. Kalb has extensive experience managing psoriasis, atopic dermatitis, and other inflammatory skin diseases. He has authored 70+ publications and is actively involved in clinical research, particularly focused on new treatment options for psoriasis. He is a member of the NPF Medical Board, American Academy of Dermatology, and is a member of the International Psoriasis Council. Sergio Schwartzman, MD, is a world-renowned rheumatologist based in New York City who brings almost 40 years of experience and personalized clinical care for those who have psoriatic disease. Along with being in private practice at Schwartzman Rheumatology, Dr. Schwartzman is a Clinical Associate Professor of Medicine at Weill Cornell Medical College of Cornell University, the New York-Presbyterian Hospital, and the Hospital for Special Surgery in New York City where he has played a role in educating medical students, residents, fellows, and peers in rheumatology. Additionally, Dr. Schwartzman is the emeritus Franchellie M. Cadwell Clinical Associate Professor at the Hospital for Special Surgery. Dr. Schwartzman’s current research interests include psoriatic arthritis, the spondyloarthritis group of diseases, ankylosing spondylitis, rheumatoid arthritis, as well as defining and treating autoimmune diseases of the eye. He has authored, co-authored, and edited over 150 papers, abstracts, books and book chapters on topics including psoriatic arthritis, ankylosing spondylitis, axial spondylarthritis, rheumatoid arthritis, lupus, autoimmune eye disorders, and other rheumatological and autoimmune conditions. He is a member of the NPF Medical Board. He is also a member of the American College of Rheumatology, the Association for Research in Vision and Ophthalmology, the Spondyloarthritis Research and Treatment Network (SPARTAN), the American Uveitis Society, and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Resources: Ø “” Advance Online, National Psoriasis Foundation. S. Schlosser. July 14, 2025. Ø Ø /episode/index/show/psoundbytes/id/38719530

Ep. 264 "Vaccines and Psoriatic Disease: What You Need to Know" 10/16/2025

Ep. 264 "Vaccines and Psoriatic Disease: What You Need to Know" Episode Description: Not sure if you should receive a vaccine given your psoriasis or psoriatic arthritis medication? Dermatologist Dr. Jason Hawkes explores this question along with vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis. Listen as hosts Jeff Brown and LB Herbert discuss key questions about vaccine use and psoriatic disease with dermatologist and NPF Medical Board member Dr. Jason Hawkes who is co-owner, Chief Scientific Officer, and investigator with the Oregon Medical Research Center. Hear what the difference is between live and non-live vaccines, how type of vaccine and immunosuppressive medications impact the timing of vaccines in relation to treatment half-lives. Get your questions answered. The intent of this episode is to offer answers to questions about vaccine use for people with psoriasis and psoriatic arthritis who take immunosuppressive treatments. Timestamps: (0:23) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Jason Hawkes. (1:15) In general, what is a vaccine and how it works in the body. (2:08) Will vaccines provide the same level of protection in people with psoriatic disease who are on treatments that influence the immune system. (4:53) The difference between live and non-live vaccines. (8:57) Summary of NPF Vaccine Recommendations in relation to live and non-live vaccines and specific medications for psoriatic disease, including a definition of medication half-lives. (13:38) Vaccines that may be recommended prior to starting a systemic medication or biologic. (18:27) The mRNA vaccine – how it works in comparison to other vaccines. (22:31) How long immunity lasts from childhood vaccines. (25:24) The vaccine guidelines apply to both psoriasis and psoriatic arthritis with some nuances. (28:38) Which healthcare provider to turn to for advice about vaccines and why. (31:54) Questions to ask your health care provider about vaccines. (33:26) How clinical trials and registries are evolving to assess the effect of vaccines with specific medications and the need for greater understanding. (36:44) Develop a good relationship with your health care provider and don’t be afraid to ask questions about your psoriatic disease, vaccines, or specific medications. Key Takeaways: · Vaccines work to help protect the body or stimulate protection against common infections or pathogens. There are different types that can be classified as either live or non-live vaccines. · Evidence-based vaccine recommendations are available for people with psoriasis and psoriatic arthritis to help guide timing of when to receive live and non-live vaccines when taking immunosuppressive oral systemic medications and/or biologics. · It’s important to discuss which vaccines to consider, and how current psoriasis medication could impact the intended response and timing with your health care team which includes a primary care physician, a dermatologist, and/or rheumatologist. Guest Bio: Dermatologist Jason Hawkes, M.D., MS is Co-owner, Chief Scientific Officer and Investigator with Oregon Medical Research Center (OMRC) in Portland, Oregon. He is also a Clinical Assistant Professor of Dermatology at Oregon Health and Science University and the President and Sole Member of Hawkes Dermatology. Prior to joining the Oregon Medical Research Center, Dr. Hawkes held academic faculty appointments in the Departments of Dermatology at the University of Utah School of Medicine, Icahn School of Medicine at Mount Sinai, and University of California-Davis. Dr. Hawkes’ principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, chronic urticaria (hives), and eczema. He has a special interest in translational human research and the development of novel biologics and small molecules used for the treatment of inflammatory conditions. Dr. Hawkes is also a Councilor of the International Psoriasis Council (IPC) and serves on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF) where he participates in the development of clinical consensus statements. Resources: Psound Bytes™ podcast with Dr. Sandy Chat (University of California) and Dr. Christoph Ellebrecht (Dept. of Dermatology, University of Pennsylvania). /episode/index/show/psoundbytes/id/38602200

Ep. 263 "Let’s Talk: Know Your Medicare Options and What Changes Mean for You" 10/09/2025

Ep. 263 "Let’s Talk: Know Your Medicare Options and What Changes Mean for You" Episode Description: Listen as Kim Beer, Senior Vice President of Policy and External Affairs with the National Health Council, and Dermatologist, Dr. Jeffrey Cohen discuss the 2025 Medicare changes in relation to psoriatic disease and what’s to come in 2026 with Jason Harris, Vice President of Government Relations and Advocacy at NPF. Join this discussion about what changes occurred with Medicare in 2025 that impact psoriatic disease care, outcomes to date, what’s to come in 2026, and what you should consider when choosing health care plans during open enrollment with Kim Beer, Senior Vice President of Policy and External Affairs with the National Health Council, Dermatologist, Dr. Jeffrey Cohen, Director of the Psoriasis Treatment Program at Yale University School of Medicine, and Jason Harris, Vice President of Government Relations and Advocacy at NPF. The intent of this episode is to increase knowledge of the 2025 Medicare changes, what’s to come, and how such changes impact psoriatic disease from coverage of prescriptions to overall health care. This episode is sponsored by Novartis. Timestamps: (0:24) Intro to Psoriasis Uncovered and guest welcome Kim Beer, Senior Vice President of Policy and External Affairs with the National Health Council, and Dermatologist, Dr. Jeffrey Cohen, Director of the Psoriasis Treatment Program at Yale School of Medicine. (2:25) Perspectives on current health care coverage in Medicare. (5:14) Biggest changes to Medicare in 2025. (6:36) What is the Medicare Prescription Payment Plan and price negotiation for specific medications. (8:22) Challenges associated with the 2025 Medicare changes from a physician’s perspective. (13:10) Price negotiation process via CMS (Centers for Medicare and Medicaid Services) with the first 10 drugs price effective in 2026. (17:52) Plan ahead and what to anticipate when choosing the right Medicare plan. (20:04) What the National Health Council and other patient advocacy organizations are doing to assess the impact of the CMS changes and identify steps for moving forward. (21:49) Medicare changes for 2026 that affect deductibles for health care services, prescription drug coverage, and vaccinations. (28:38) Potential assistance options for people who have Medicare insurance. (31:32) The role of patients in providing feedback on policy changes. (33:45) Changing from a commercial insurance plan to a Medicare Plan and what to think about when viewing plan options during the open enrollment period. (37:07) Be part of the process – let your voice be heard by sharing your experiences to help effect change. 3 Key Takeaways: · There are four key parts to Medicare health insurance (Part A, B, C and D) which underwent changes in 2025 including a payment cap for prescriptions and availability of a 12 month Prescription Payment Plan to opt in for medications. Additional changes are coming in 2026 including enactment of a price negotiated list of 10 medications. · The impact of such changes are both positive (better predictability and affordability) yet also reactionary. Such changes and potential impact should be considered when identifying plan coverage for health care and prescriptions during the open enrollment Medicare period of October 15 to December 7th. · Be involved by telling your story about the impact of Medicare changes and find a trusted health care provider who is willing to work with you to identify an effective treatment plan that aligns with your health care needs and coverage. Guest Bios: Dermatologist Jeffrey Cohen, M.D., MPH, is the Director of the Psoriasis Treatment Program and the Director of Safety with the Department of Dermatology at Yale University School of Medicine where he is also an Associate Professor of Dermatology and Biomedical Informatics and Data Science. Dr. Cohen treats a variety of skin conditions with a special interest in diseases of the immune system such as psoriasis and eczema tailoring treatments for each individual. He is the author of over 150 peer-reviewed articles on psoriasis and other topics in dermatology. Dr. Cohen serves on the Editorial Board of the Journal of the American Academy of Dermatology, is a Senior Editor for NPF’s professional journal for health care providers Journal of Psoriasis and Psoriatic Arthritis, is a Councilor of the International Psoriasis Council, and serves on the Medical Board of the National Psoriasis Foundation. Kimberly (Kim) Beer is Senior Vice President of Policy and External Affairs at the (NHC) of which the National Psoriasis Foundation is a member. Kim leads strategic policy initiative and advocacy efforts to improve the lives of individuals with chronic conditions and disabilities. As a member of the NHC’s executive leadership team, she helps to ensure access to high-quality, affordable healthcare for all Americans which includes advocating for policy and health care benefits within Medicare. Resources: For more reources and information about Contact the to learn more about Medicare, find a health care provider, learn about treatments, or programs that may lower costs. /episode/index/show/psoundbytes/id/38519915

Ep. 262 "Finding My Path to Managing Psoriatic Disease and Excess Weight" 08/28/2025

Ep. 262 "Finding My Path to Managing Psoriatic Disease and Excess Weight" Dermatologist Dr. Erin Boh and patient advocate Brian Lehrschall discuss the challenge of managing weight, psoriasis, and psoriatic arthritis which share common inflammatory pathways and what can be done to improve all together. Join moderator Jennifer Bomberger as she asks what is the connection between psoriatic disease and excess weight and what can be done to counter the effects of inflammatory cytokines for both with leading dermatologist Dr. Erin Boh and Brian Lehrschall who has lost over 100 pounds using diet, exercise and a GLP-1 receptor agonist. Hear Brian’s story along with what is a GLP-1, how they work, and side effects. The intent of this episode is to offer knowledge and an example of how a GLP-1 can be used successfully to improve the outcomes and management of psoriasis and psoriatic arthritis. This episode is sponsored by . A Word of Warning This episode contains information about the body, like body size, weight management, healthy eating, and lifestyle changes. If you have a history of disordered eating or are struggling with body-related mental health challenges, you might wish to explore some of our . There are clinical terms used by our speakers about body size or body weight that you might find triggering. Key among them is the word ‘.’ While it is the scientifically correct name for a disease and a common clinical term, NPF acknowledges that this word is triggering and problematic, and it is used only for the clearest of accuracy. Timestamps: (0:23) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Erin Boh and Brian Lehrschall, who has been living with psoriatic disease for over 30 years and has recently lost over 100 pounds. (1:32) Health challenges Brian faced while trying to manage his weight, psoriasis, and psoriatic arthritis. (4:08) Many factors contribute to psoriasis, psoriatic arthritis, and comorbidities. (5:56) Discussing the sensitive subject of losing weight and changing lifestyle. (7:57) The inflammatory pathways and connection between excess weight and psoriatic disease. (14:50) Tips for managing multiple diseases like psoriatic disease, depression, and excess weight together. Realize “it’s not your fault”. (21:32) Are low calorie or anti-inflammatory diets effective with psoriasis? (25:21) The definition of a GLP-1 (receptor agonist), how they work, and benefits in resetting how the body functions. (30:02) Brian’s experience and impact of using a GLP-1. (32:08) Current and future use of GLP-1 in the management of psoriatic disease, comorbidities, and excess weight. (34:49) Be an advocate for yourself to help do all the things that will make you feel better about living with psoriasis and psoriatic arthritis. Key Takeaways: · Obesity or excess weight is a disease driven by an overproduction of inflammatory cytokines. · Psoriasis, psoriatic arthritis, and excess weight have shared pro-inflammatory disease pathways that should be considered together when identifying an effective treatment plan. · GLP-1 receptor agonists can be used along with dietary changes and exercise to induce weight loss that improves the body’s reaction to medications used to treat psoriasis and psoriatic arthritis. Guest Bios: Erin Boh, M.D., Ph.D. is the Joseph Chastain Endowed Chair of Clinical Dermatology at Tulane University, School of Medicine where she is also a Professor and Chairman of Dermatology. Her clinical and research focus includes photobiology, chronic diseases such as psoriasis, psoriatic arthritis, and skin cancers such as lymphoma. Dr. Boh is a past Medical Board member of the National Psoriasis Foundation and is currently a President’s Council Member which represents an elite group of health care providers who are committed to the mission of the Foundation and finding a cure for psoriasis. Dr. Boh has published many articles including addressing today’s topic about weight management and inflammation in psoriasis. Brian Lehrschall has lived with psoriatic disease for three decades. He was first diagnosed with psoriasis about thirty years ago, at the age of 13 and with psoriatic arthritis at age 15. With the diagnosis came bullying which led to emotional eating. Per Brian “The more I ate, the worse the weight got.” Like most people who are overweight Brian tried to improve his health with diet and exercise. Along the way he learned about the connection between psoriasis and excess body weight. Eventually a physician recommended he try the weight loss medication GLP-1 (Glucagon-like peptide-1). Using this medication he has lost over 100 pounds and is still losing weight along with improving his overall health which includes his psoriasis and psoriatic arthritis. Brian joined the National Psoriasis Foundation in 2000 as a volunteer and has become an advocate for improving access to care and sharing his story about living with psoriatic disease. Resources: Ø “” Advance Online. M. Werbach. July 17,2025. Ø “ podcast episode with dermatologist Dr. Adam Ford and registered dietitian, Danielle Baham. Ø Find the support you need through the /episode/index/show/psoundbytes/id/37997715

Ep. 261 "Defining On Treatment Remission for Psoriasis and What it Means for You" 08/19/2025

Ep. 261 "Defining On Treatment Remission for Psoriasis and What it Means for You" Leading dermatologist and NPF Medical Board Member, Dr. Tina Bhutani, and Gail Reiser who lives with plaque psoriasis discuss what “on treatment remission” means for those who have the disease and health care providers. Join moderator and resident physician Olivia Kam as she discusses the definition of on treatment remission for plaque psoriasis, and how this definition impacts the management of the disease and when to change treatments with leading dermatologist Dr. Tina Bhutani from Synergy Dermatology in San Francisco, and Gail Reiser who has been living with plaque psoriasis for over 42 years experiencing a variety of treatment options. The intent of this episode is to increase knowledge of the latest consensus statement defining what “on treatment remission” means in the context of managing plaque psoriasis and how such information can be used to guide patient/provider discussion and setting treatment goals. This episode is sponsored by . Timestamps: (0:23) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Tina Bhutani and Gail, who has been living with plaque psoriasis for over 42 years. (1:56) Definition of “on treatment remission” and development of this unified consensus statement that included almost 100 stakeholders. (3:28) How the definition of “on treatment remission” impacts management of psoriasis. (5:09) A patient’s perspective about “on treatment remission” and what it means for future care. (8:57) Assessing when a change in treatment may be appropriate. (11:19) What information a dermatologist can provide to assess if treatment is effective. (14:20) Prioritizing what to discuss with a dermatologist or health care provider. (17:21) Call to action for dermatologists from the “On Treatment Remission” consensus statement. (20:37) Advice for discussing treatment goals as a patient and health care provider. Key Takeaways: · A new consensus statement helps define and standardize what “On Treatment Remission” is and what it means for patient care. · Given current treatment options it is possible to reach skin clearance and on treatment remission. · Having standardized goals makes it easier for health care providers and patients who have psoriatic disease to work together to reach on treatment remission. Guest Bios: Tina Bhutani, M.D., MAS, is a board-certified dermatologist who is the CEO and owner of Synergy Dermatology in San Francisco. Dr. Bhutani is also an Associate Clinical Professor of Dermatology at UCSF where she previously co-directed the Psoriasis and Skin Treatment Center and directed the Clinical Trials Unit for over 8 years. Dr. Bhutani understands the importance of treating the whole patient and is committed to a patient-centered approach to dermatology. She is a recognized leader in dermatology, giving talks at many national and international meetings. Dr. Bhutani is a member of the National Psoriasis Foundation Medical Board who recently published a consensus statement called “Defining On Treatment Remission in Plaque Psoriasis” in JAMA Dermatology. Gail Reiser was initially diagnosed with plaque psoriasis at age 12. She remembers the misdiagnoses and difficult treatments of the past such as coal tar and occlusion. Over 42 years of living with plaque psoriasis, Gail has experienced a variety of treatment options including topicals and light therapy, feeling “it is exhausting to treat psoriasis”. As she got older and her plaque psoriasis progressed, she eventually decided to try biologics and hasn’t looked back since making that change. She feels her psoriasis is in remission but fears losing that in the future. Resources: Advance Online, National Psoriasis Foundation. S. Schlosser. July 14, 2025. To hear other perspectives about living with psoriasis through the resource Gail mentioned: . /episode/index/show/psoundbytes/id/37870300

Ep. 260 "Learning How to Navigate Psoriatic Disease Together as a Family" 08/12/2025

Ep. 260 "Learning How to Navigate Psoriatic Disease Together as a Family" Pediatric rheumatologist Dr. Pamela Weiss speaks with Michael and his 12 year old daughter Ava about navigating the challenge of living with psoriasis and psoriatic arthritis together as a family. Join moderator Kaleigh Welch as she discusses the challenges of living with psoriasis and juvenile psoriatic arthritis (JPsA) from diagnosis, misconceptions about psoriatic disease, to management and treatment with pediatric rheumatologist, Dr. Pamela Weiss from Children's Hospital of Philadelphia, Division of Rheumatology, along with Michael and Ava, whose psoriatic disease is truly a family affair. The intent of this episode is to raise awareness about the complexities and nuances associated with living with psoriasis and psoriatic arthritis as a child or an adult and not letting the disease stop you from doing what you love to do. This episode is sponsored by Amgen. Mike, Ava, and Dr. Weiss were compensated for their time. Timestamps: · (0:00) Intro to Psoriasis Uncovered and guest welcome pediatric rheumatologist Dr. Pamela Weiss, Michael and Ava Sayles who both have been diagnosed with psoriasis and psoriatic arthritis. · (1:28) What the psoriatic disease diagnosis process could be like for children and adults. · (5:34) Misconceptions associated with psoriasis leading to delayed diagnosis of psoriatic arthritis. · (7:36) What people misunderstand about plaque psoriasis and psoriatic arthritis. · (11:06) Challenges to finding the right treatment while living life with psoriatic disease. · (17:24) What drives treatment choices for psoriatic disease in youth. · (19:59) Assessing what’s most important in reaching treatment goals. · (23:57) What the future holds for management of Juvenile Psoriatic Arthritis (JPsA). · (26:10) Living with psoriatic disease is challenging but find what’s right for you and don’t give up on what you love to do. Key Takeaways: · Diagnosis of plaque psoriasis and psoriatic arthritis can be challenging given subtleties that can occur in the presentation of the disease in adults and children. · There are a variety of treatments that work either alone or in combination to treat plaque psoriasis and psoriatic arthritis with choice of treatment dependent on what is the primary goal for the individual’s physical and emotional health. · The future is bright as understanding of the disease increases and treatment options expand and become more targeted to more effectively address skin and joint issues associated with psoriatic disease. Guest Bios: Pamela Weiss, M.D., MSCE, is a pediatric rheumatologist and the Clinical Research Director of the Division of Rheumatology at Children's Hospital of Philadelphia. Dr. Weiss is also the Distinguished Endowed Chair in the Department of Pediatrics. She has advanced training in clinical epidemiology with a focus on early diagnosis, and targeted treatment of children with spondyloarthritis (SpA). Dr. Weiss is also a Professor of Pediatrics and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania. She is a member of the American Academy of Pediatrics, American College of Rheumatology, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the Spondylitis Association of America, and the SPondyloArthritis Research & Treatment Network (SPARTAN). Michael and Ava Sayles, psoriatic disease is a family affair. Both father and daughter, successfully navigate living with plaque psoriasis and psoriatic arthritis. Michael or Mike was diagnosed in his twenties, and Ava at age 7 and then later on juvenile psoriatic arthritis. She is now 12 years old. They have experienced issues with diagnosis, and a long journey of finding treatment options that worked for them. Mike found the best solution was establishing a routine or rhythm of treatment around work and school to avoid flare-up’s if possible, saying “keeping on top of what you need to do for the psoriasis and the arthritis becomes a big part of your life". Resources: /episode/index/show/psoundbytes/id/37768600

Ep. 259 "Uncovering Scalp Psoriasis" 08/07/2025

Ep. 259 "Uncovering Scalp Psoriasis" Is it scalp psoriasis or something else? If it is scalp psoriasis what do I do about it? These questions and more are answered by leading dermatologist Dr. Ronald Prussick as we uncover what is scalp psoriasis. Join host Corinne Rutkowski as she talks with dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD about scalp psoriasis compared to dandruff, seborrheic dermatitis or eczema, and how characteristics may differ, along with what treatments and actions are effective to address scalp psoriasis. This episode offers helpful insights and tips to address symptoms and care of scalp psoriasis. Timestamps: · (0:00) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick. · (1:19) What is dandruff and key characteristics. · (2:28) Treatments for dandruff. · (3:28) What is seborrheic dermatitis and characteristics. · (4:18) Treatment options for seborrheic dermatitis. · (7:04) How scalp psoriasis compares to dandruff, seborrheic dermatitis or eczema, and what are the key differences. · (9:24) Why scalp psoriasis is a high impact site and how itching of the scalp leads to Koebnerization. · (12:46) Prescription and over the counter treatment options for scalp psoriasis. · (18:11) Tips for using shampoos and applying treatments on the scalp. · (24:08) Hair loss or alopecia with scalp psoriasis. · (25:22) Upcoming treatments for scalp psoriasis. · (27:38) Most important point to know about scalp psoriasis. Key Takeaways: · Some skin diseases may be confused with scalp psoriasis, however psoriasis does have key characteristics which helps lead to a definitive diagnosis. · Scalp psoriasis is a high impact area meaning body surface area (BSA) is less than 10% however impact on quality of life is significant and is a factor in determining choice of treatment(s) whether prescription or over the counter. · Be aware of the risks for Koebnerization of the scalp and take precautions to minimize itching and scratching through application of treatments and care of the scalp. Guest Bio: Leading dermatologist Ronald Prussick, M.D., is Vice Chair of the Medical Board for the National Psoriasis Foundation and the Medical Director of Washington Dermatology Center in Rockville and Frederick, MD where he specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails using the latest technology and products. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, DC. He has been published many times and frequently speaks at medical conferences across the country and internationally including providing podcast episodes, such as on Psound Bytes addressing facts about nutrition and psoriasis in episode #196 . Dr. Prussick has been voted one of the top doctors by the Washingtonian Magazine time after time and has been repeatedly named one of America’s Top Physicians by the Consumers Research Council. Resources: Ø Ø To find a dermatologist if needed: Ø /episode/index/show/psoundbytes/id/37712545

Ep. 258 "Treating Plaque Psoriasis From the Inside Out" 07/29/2025

Ep. 258 "Treating Plaque Psoriasis From the Inside Out" Hear Christopher McKim’s journey with moderate to severe plaque psoriasis and the latest clinical trial results from dermatologist, Dr. Christine Cornejo. Join this discussion with moderator Archie Franklin as Christopher McKim, a BMS employee living with moderate to severe plaque psoriasis, and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at BMS, offer a patient and physician’s perspective on treating plaque psoriasis from the inside. Listen as Chris presents his journey along with Dr. Cornejo addressing effectiveness and safety information with clinical trial results for a prescription oral treatment option. The intent of this episode is to encourage those who have moderate to severe plaque psoriasis to work with their health care provider to find a treatment option that is right for them. This episode is sponsored by Bristol Myers Squibb. For more information view and . · (0:00) Intro to Psoriasis Uncovered and guest welcome to Bristol Myers Squibb employee and patient Christopher McKim and Dr. Christine Cornejo, Director and US Medical Engagement Lead for Dermatology and Rheumatology at Bristol Myers Squibb. · (2:15) Where the journey to finding the right treatment option for Chris and his moderate to severe plaque psoriasis began. · (3:09) The decision by Chris and his provider to try an oral systemic medication. · (3:28) The effects and impact of an oral systemic treatment for Chris and his plaque psoriasis. · (4:09) Dr. Cornejo addresses efficacy and clinical trials results. · (5:58) Common side effects and safety concerns for the treatment Chris and his health care provider decided to try. · (6:28) Health considerations patients and providers should discuss prior to using a systemic treatment. · (6:54) What to do should side effects occur. · (7:10) How Chris feels with clearer skin after making a change in treatment. · (8:14) Indication and Important Safety Information. Key Takeaways: · Moderate to severe plaque psoriasis is a systemic disease. · If you’re ready to treat from the inside there is a treatment option that may help. · Work with a health care provider to find the right treatment for moderate to severe plaque psoriasis. · Be proactive by taking steps to learn about treatment options including effectiveness, side effects, safety concerns, and what should be discussed with a health care provider before beginning a new treatment for plaque psoriasis. Guest Bios: Christopher (Chris) McKim joined BMS in June of 2022. In his current role he is a Regional Marketer for the dermatology division, prior to that he provided support for 9 Therapeutic Area Specialists for the Pacific South District in the GI division. Prior to joining BMS, Chris worked at Sanofi, J&J, Leo Pharma, and Sun Pharma in various field and home office roles. Chris resides in beautiful San Diego with his family Susan (wife), Morgan 18, Maddy 16, Mason 14 and two Golden Retrievers and enjoys traveling, cooking and anything associated with the ocean (Deep Sea Fishing, S.C.U.B.A. diving, snorkeling, and boogie boarding). Dr. Christine Cornejo joined Bristol Myers Squibb in 2024 as Director, Medical Engagement Lead for Dermatology and Rheumatology. Prior to joining BMS, she practiced dermatology at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston, MA, where she specialized in melanoma and high-risk skin cancer management and served as the Director of Confocal Microscopy. She also served as an Instructor at Harvard Medical School and led the Immunology and Infectious Diseases course for 1st year medical students. Resources: For additional questions about treatment options contact the /episode/index/show/psoundbytes/id/37587255

Ep. 257 "Traveling Near and Far with Psoriatic Disease" 07/15/2025

Ep. 257 "Traveling Near and Far with Psoriatic Disease" Feeling adventurous but not sure how to travel with your psoriasis and psoriatic arthritis? Listen as certified physician assistant Rosemary Son offers tips to help make your care easier while traveling near or far. Join hosts LB Herbert and Kaitlin Walden as they talk tips for making travel easier whether in the US or abroad with certified Physician Assistant Rosemary Son from UT Southwestern Medical Center. Listen in as they discuss what to pack, keeping medications including biologics cool, where to find help if needed, tips for navigating airline travel, vaccines for traveling abroad, managing travel stress, infection precautions, and more. This episode offers information to help you prepare in advance for that trip of a lifetime while maintaining management of your psoriasis and psoriatic arthritis so you can feel free to live your life to its fullest. Timestamps: · (0:00) Intro to Psoriasis Uncovered & guest welcome certified Physician Assistant Rosemary Son. · (2:43) Tips for keeping medications (including biologics) cool when traveling in hot weather. · (5:37) Types of skin and pain management products to pack. · (8:41) Where to find help for psoriatic disease if needed in unfamiliar places. · (10:43) Preparing for airline travel including liquid limitations and developing a “psoriasis passport”. · (14:33) Travel to other countries and how to find over-the-counter medications if needed. · (16:43) Vaccine recommendations for out of the country travel. · (19:02) Cold weather protection recommendations. · (21:27) Precautions for reducing risk of infection and should you purchase travel insurance. · (24:17) Tips for managing stress as a disease trigger while traveling. · (28:56) What to avoid when traveling. · (31:36) Live life to the fullest with psoriatic disease and enjoy the adventure travel offers. 3 Key Takeaways: · Managing psoriasis and psoriatic arthritis while traveling near or far is possible with advance preparation and use of precautions to help avoid stress associated with travel in changing environments. · What and how you pack is key to reducing potential health issues that occur while traveling. · A “psoriasis passport” or letter from your physician and a list of generic names for your medications can make travel in and out of the country easier. Guest Bio: Rosemary Son, M.P.A.S., PA-C, RDN is a board-certified physician assistant in the Department of Dermatology at the University of Texas (UT) Southwestern Medical Center and Parkland Health and Hospital System. As a dual-certified Physician Assistant and Registered Dietitian with over a decade of experience in dermatology, Rosemary has a passion for treating complex inflammatory skin diseases such as psoriasis, atopic dermatitis, hidradenitis suppurativa, as well as, treating diseases that impact skin of color, and identifying social determinants of dermatologic health. She also has a personal passion for travel. Ms. Son is a Director at Large and member of the Society of Dermatology Physician Assistants and the American Academy of Physician Associates serving as a liaison to the American Academy of Dermatology. Resources: Ø Ø /episode/index/show/psoundbytes/id/37406915

Ep. 256 "The Psoriasis Partnership: How Proactive Care & Biologics Changed My Life" 06/26/2025

Ep. 256 "The Psoriasis Partnership: How Proactive Care & Biologics Changed My Life" Join us to hear Jennifer's incredible unexpected journey from mysterious, itchy skin blotches leading to a full psoriasis diagnosis and how she found the right treatment for her with dermatologist Dr. Christina Feser and Mind.Px. Listen as Jennifer tells her diagnostic odyssey from itchy, skin blotches to psoriasis with host Max Blitstein as together they explore her journey from topical treatments to biologics, and the emotional toll this disease can take. Learn how this psoriasis patient found relief with Dr. Christina Feser through the use of new precision medicine technology to find the right treatment for her. This episode highlights the importance of proactive care and the life-changing impact of finding the right medical support. Timestamps: · (0:00) Intro to Psound Bytes™ and guest welcome dermatologist Dr. Christina Feser and her patient Jennifer Kirsch. · (1:26) Jennifer’s life prior to her diagnosis journey with psoriasis. · (2:29) Symptoms, diagnosis, and initial treatment course. · (4:26) The path to taking control of Jennifer’s psoriasis begins with a Mind.Px test. · (9:15) Timeline for the Mind.Px test results and how it felt to get the test. · (12:14) Implementation and results of the treatment recommended by Dr. Feser and the Mind.Px test. · (17:22) The emotional impact of living with psoriasis. · (19:24) Be proactive when something is not right. Listen to your body. · (19:57) Getting on the right medicine initially has value. · (21:16) While the journey is not easy, taking advantage of available technology offers better management of patients with psoriasis. 3 Key Takeaways: · Diagnosis of psoriasis can be challenging but it all starts with finding the right health care provider who listens to you as a patient. · Technology now exists through Mind.Px to help providers and patients select a therapy that is more biologically appropriate to manage their psoriasis. · Be proactive in taking steps to ensure you receive the right treatment for you and your health. Guest Bios: Dr. Christina Feser is a board-certified dermatologist with Nashville Skin, a comprehensive dermatology center for adults and children where she specializes in the latest medical treatments for skin diseases such as psoriasis that impact the skin, scalp, hair, and nails. She has a passion for research, serving as Principal Investigator on numerous clinical trials with a focus on psoriasis, eczema, alopecia, vitiligo, and other skin diseases. She is a fellow of the American Academy of Dermatology, the American Osteopathic College of Dermatology, and is a member of the Nashville Dermatology Society and the Tennessee Dermatology Society. Jennifer Kirsch, a patient of Dr. Feser’s, was diagnosed with psoriasis in November 2024 after initially being diagnosed with eczema. Taking matters into her own hands, Jennifer not only found the right care with Dr. Feser, but also the right treatment to help her live her life without the itch associated with psoriasis. Resources: Ø Current Biologics on the Market Ø /episode/index/show/psoundbytes/id/37153855

Ep. 255 "GPP is Far More Than Just Psoriasis" 06/17/2025

Ep. 255 "GPP is Far More Than Just Psoriasis" Having Generalized Pustular Psoriasis (GPP) can steam roll your life. Hear how dermatologist Dr. Oanh Lauring and patient advocate Jordan Hicks overcame the challenge of recognition to treating this rare form of psoriasis. GPP is far more than just psoriasis. Recognition of this form of psoriasis with a unique cytokine presents challenges when symptoms are not so apparent and confusing. Join host Alan Simmons as he dives into the diagnosis journey, and treatment from acute to chronic flares with dermatologist Dr. Oanh Lauring, and what it means to live and stand up for yourself with GPP with Jordan Hicks. This episode offers a heartfelt look at life with generalized pustular psoriasis (GPP) and the value of standing up for your health. Join GPP Awareness Day in August. Timestamps: · (0:00) Intro to Psound Bytes & guest welcome dermatologist Dr. Oanh Lauring and patient advocate Jordan Hicks. · (1:08) Jordan’s diagnosis journey with generalized pustular psoriasis (GPP). · (2:37) What is generalized pustular psoriasis and Dr. Lauring’s first encounter with GPP. · (8:00) How GPP is different from plaque psoriasis but they can coexist together. · (9:53) Treatment of acute GPP flares vs ongoing flare management. · (12:29) The impact of GPP on Jordan’s life. · (13:22) How to support those who live with GPP in the clinic setting and their mental health. · (15:24) Tips for working with other specialists in management of GPP. · (17:30) Feelings associated with being diagnosed with GPP. · (20:43) Being a self-advocate is important to your healthcare journey. · (22:18) If you have GPP, you are not alone. Initiation of GPP Awareness Day. 4 Key Takeaways: · Diagnosis of generalized pustular psoriasis can take time given its confusing presentation in the early stages but can shift rapidly to urgent care when in the acute phase of the disease. · Generalized pustular psoriasis and plaque psoriasis are distinct forms but can coexist together. 50% of patients with GPP also have plaque psoriasis. · The impact of living with GPP is significant and finding support from those who understand, including health care providers, is critical to treating and coping with the disease. · If you have GPP be a strong advocate for your health and your self-worth. Your symptoms are valid and you deserve to be heard. Guest Bios: Dr. Oanh Lauring is a board-certified dermatologist in private practice at Lauring Dermatology where she provides the utmost care and expertise for patients with serious skin diseases such as psoriasis that impact the skin, scalp, hair, and nails. She offers a variety of the latest medical treatments including generalized pustular psoriasis to help her patients achieve a natural and refreshed appearance. Jordan Hicks took her health into her own hands. She moved from a small Texas town to Las Vegas in order to obtain care for her generalized pustular psoriasis or GPP. Once there she found her community and learned to speak up for herself and others. Jordan and her dog have been active advocates for GPP and Psoriasis ever since. Resources: Ø Find Support through GPP Circles and others who understand what it means to live with GPP Ø Join us to create awareness for the first GPP Awareness Day August 13, 2025. Request your tool kit. /episode/index/show/psoundbytes/id/36973470

Ep. 254 "If You Have Psoriatic Disease Keep an Eye Out for Uveitis" 06/03/2025

Ep. 254 "If You Have Psoriatic Disease Keep an Eye Out for Uveitis" Have a red, painful eye that’s sensitive to light? Could be uveitis. Hear ophthalmologist Dr. Timothy Janetos discuss uveitis and how it relates to psoriasis and psoriatic arthritis. Join host Takieyah Mathis for an eye opening discussion about uveitis, cataracts, and eye health with ophthalmologist Dr. Timonthy Janetos from Northwestern Medicine, Department of Ophthalmology. Listen as they discuss what is uveitis and cataracts from key symptoms, the significance of the HLA-B27 marker, diagnosis, to treatment options that help reduce inflammation and preserve long term vision. This episode offers information to help you advocate for your eye health by recognizing when you need help from an ophthalmologist and what actions you can take to reduce your risks associated with uveitis. Timestamps: · (0:00) Intro to Psound Bytes & guest welcome ophthalmologist Dr. Timothy Milton Janetos. · (1:21) Definition of uveitis and the relationship to psoriatic disease. · (5:35) Symptoms of uveitis. · (7:45) How uveitis is diagnosed. · (9:24) Treatment options for uveitis. · (13:11) What happens if eye injections are needed as treatment. · (14:47) Association between inflammation, psoriatic disease, and cataracts. · (15:48) Symptoms of a cataract. · (16:33) Treatment for cataracts. · (21:11) New advancements in treating uveitis and cataracts. · (25:50) General eye health actions to help reduce risks associated with inflammation. Early detection is key. 4 Key Takeaways: · Uveitis is a huge spectrum of different diseases with about half of the associations due to chronic, immune related diseases like psoriasis or psoriatic arthritis. · If you wake up with a red, painful eye that’s sensitive to light, seek help from an ophthalmologist right away to minimize risk of scar tissue formation. · Work with a health care team to treat all aspects of psoriatic disease to reduce inflammation whether it’s in the skin, joints, and/or the eye. · Lifestyle changes such as stop smoking and yearly eye exams are actions that can help reduce inflammatory factors and maintain overall eye health. Guest Bio: Dr. Timothy Milton Janetos is a board-certified and nationally recognized ophthalmologist with Northwestern Medicine, Department of Ophthalmology who specializes in uveitis and cataract surgery. He is also an Assistant Professor at the Feinberg School of Medicine, Department of Ophthalmology. Dr. Janetos offers comprehensive care using a personalized treatment plan for both children and adults with intraocular inflammation and infections. He is a professional member of the American Uveitis Society (AUS) and the Association for Research in Vision and Ophthalmology (ARVO), as well as the Editor for Frontiers in Ophthalmology and an Editorial Board Member for Annals of Eye Science. Resources: Ø Psoriatic Arthritis and Uveitis: What’s it All About? Podcast with rheumatologist and ophthalmologist Dr. James Rosenbaum. (Released in 2019.) Ø Eye Inflammation and Psoriatic Arthritis /episode/index/show/psoundbytes/id/36829655

Ep. 253 "Inflammation is Bad for Bone: Osteoporosis and Psoriatic Disease" 05/29/2025

Ep. 253 "Inflammation is Bad for Bone: Osteoporosis and Psoriatic Disease" Osteoporosis is a silent disease. There is no pain or other symptoms but inflammation in the gut and joints is a risk factor. Learn about your risks and what you can do for osteoporosis from rheumatologist Dr. Diana Sandler. Join host Corinne Rutkowski, a third year medical student, as she explores the relationship between osteoporosis and psoriasis with leading bone health expert and rheumatologist Dr. Diana Sandler. Listen as they discuss the difference between osteoporosis and osteoarthritis, bone density testing, how prolonged inflammation is a key risk factor especially for psoriatic arthritis, along with treatments and actions you can take to minimize your risk of osteoporosis and fractures. Do what you can to protect your bone health and function as you age. Timestamps: (00:00) Intro to Psound Bytes & guest welcome rheumatologist Dr. Diana Sandler. (01:23) Risk factors and difference between osteoporosis and osteopenia. (03:10) Difference between osteoporosis and osteoarthritis, which are often confused. (04:17) Diagnosis process for osteoporosis. (06:11) Risk factors for development of osteoporosis. (07:57) Is it possible to have osteoporosis or osteopenia and psoriatic arthritis together? (09:44) The role of osteoclast and osteoblasts in bone formation. (12:21) Treatment of osteoporosis. (14:10) Importance of vitamin D and calcium in the prevention of osteoporosis. (15:57) Activities that strengthen the muscles and bones to slow progression of osteoporosis. (17:08) Precautions and tips for avoiding falls. (18:59) Schedule appointments and ask for referrals early. 4 Key Takeaways: · Osteoporosis and osteoarthritis are two distinct diseases that affect joints and bone. · There are many factors that impact the development of osteoporosis including inflammatory diseases such as psoriatic arthritis, lifestyle risks, family history, use of steroids, hormone deprivation, and more. · Preventive use of bisphosphonates and other treatment strategies can be implemented to address the breakdown of bone in osteoporosis. · Various precautions can be taken to minimize and avoid falls. Guest Bio: Dr. Diana Sandler is a rheumatologist at Endeavor Health in Chicago and is a Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine where she is a leading expert in osteoporosis, psoriatic disease, and other immune-mediated diseases. Dr. Sandler is the Director of the Bone Health Center at Endeavor Health. She is also a board member of the National Psoriasis Foundation and in 2023 received the NPF Provider of the Year award in Rheumatology. Dr. Sandler is passionate about patient education and integrative team approaches when it comes to caring for patients with complex and multilevel diseases such as psoriatic arthritis, psoriasis and osteoporosis. /episode/index/show/psoundbytes/id/36760195

Ep 252 "Defining Minimal Disease Activity in Psoriatic Arthritis with rheumatologist Dr. Arthur Mandelin" 05/13/2025

Ep 252 "Defining Minimal Disease Activity in Psoriatic Arthritis with rheumatologist Dr. Arthur Mandelin" Not sure what Minimal Disease Activity or MDA is and how it relates to psoriatic arthritis and your joints? Listen as rheumatologist Dr. Arthur Mandelin explains what MDA means. Join hosts Jeff Brown and LB Herbert as they discuss minimal disease activity in psoriatic arthritis with nationally recognized rheumatologist Dr. Arthur Mandelin who identifies what it is, factors that influence achieving MDA, how long it takes to reach, and the impact on selection of treatments. Dr. Mandelin also addresses fatigue associated with inflammation, and what the future holds for minimal disease activity in psoriatic arthritis. Whether you have psoriasis or psoriatic arthritis, this episode offers information to help you understand management goals set by your doctor and the importance of attaining minimal disease activity. Timestamps: (00:00) Intro to Psound Bytes & guest welcome rheumatologist Dr. Arthur Mandelin (02:23) What is minimal disease activity (MDA) (04:32) MDA in comparison to ACR response criteria (07:36) Criteria for reaching MDA (09:20) Positive and negative factors of MDA (11:25) Importance of reaching MDA within a specific time frame (17:34) Length of time to reach MDA (18:48) Selection of treatment options and psoriatic arthritis domains (23:51) Inflammation and fatigue (26:59) A look at the future of minimal disease activity in psoriatic arthritis: Reaching ACR 90 (29:09) Advancements in psoriatic arthritis: Finding disease markers (33:40 ) If you have psoriasis, be aware of your risk for psoriatic arthritis 4 Key Takeaways: There are various ways to measure minimal disease activity in psoriatic arthritis to assess how the disease impacts quality of life. Attaining and keeping minimal disease activity low through use of different therapy options offers a chance for better bone and joint outcomes. Advancements in psoriatic arthritis include attaining ACR90 and the potential for identifying key markers that make treatment selection more targeted and individualized. Those who have psoriasis need to realize bone and joint pain, and swelling in the joints may be related to their psoriatic skin disease and seek appropriate help. Guest Bio: Dr. Arthur Mandelin is an Associate Professor of Medicine at Northwestern University Feinberg School of Medicine and the Department of Medicine Division of Rheumatology. Dr. Mandelin launched Northwestern University’s first training program in musculoskeletal ultrasonography for rheumatology fellows. He is an active participant in the REASON Group which is a multi-center research collaboration devoted to using ultrasound guidance to obtain minimally invasive synovial tissue biopsies. Dr. Mandelin is a past member of the National Psoriasis Foundation’s Medical Board where he served on consensus panels for the development of a variety of practice guidelines. Resources Mentioned: National Psoriasis Foundation: PEST Screener: PsA Action Month 2025: NSAIDS for Psoriatic Disease: AMP (Accelerated Medicines Partnership): Tags: psoriasis, skin, psoriatic arthritis, minimal disease activity, ACR20, ACR50, ACR70, tender joints, bone erosion, joint swelling, enthesitis, inflammation, pain, fatigue, axial disease, spinal involvement, treatment, NSAIDS, biologics, personalized medicine, dermatology, National Psoriasis Foundation, AMP, Psound Bytes podcast, Soundbites podcast /episode/index/show/psoundbytes/id/36545690

Ep. 251 "Managing Psoriasis in High Impact Sites is a Whole Different Ball Game" 05/06/2025

Ep. 250 "The Future of Psoriasis Care: Dr. Mona Shahriari Breaks Down New AAD Research & Personalized Treatments" 04/29/2025

Ep. 250 "The Future of Psoriasis Care: Dr. Mona Shahriari Breaks Down New AAD Research & Personalized Treatments" Explore groundbreaking updates in psoriasis and psoriatic arthritis research from the 2025 AAD Annual Meeting with dermatologist Dr. Mona Shahriari. Join host Archie Franklin and renowned dermatologist Dr. Mona Shahriari as they unpack the latest research and clinical insights into managing psoriatic disease. This episode dives into head-to-head therapeutic trials, fast-acting treatments for high-impact areas like scalp and nails, and a preview of emerging oral biologics and GLP-1 weight management therapies. Dr. Shahriari discusses real-world challenges in treating psoriasis and psoriatic arthritis, the rise of precision medicine, and how early intervention could alter disease progression. Whether you're a patient, clinician, or researcher, this conversation delivers critical updates on psoriasis care, including IL-17, IL-23, and TYK2 inhibitors, and their potential to revolutionize dermatology practice. Timestamps: (00:00) Intro to Psound Bytes & guest welcome Dr. Mona Shahriari (01:00) What the AAD 2025 conference revealed about psoriatic disease (02:10) Comparing IL-17 and IL-23 inhibitors: Trial results (06:00) Treating scalp, palmoplantar, and nail psoriasis (10:45) Genital psoriasis & the importance of psychosocial care (12:00) What’s new for Generalized Pustular Psoriasis (GPP) 14:35) The GUIDE Study: Early treatment & immune memory (18:00) Personalized medicine, oral IL-23s & emerging TYK2s (20:00) GLP-1 therapies for weight & inflammation control (23:00) Psoriasis, cardiovascular risk & comorbidities (24:00) Mental health, depression & the value of systemic treatment (26:00) A hopeful future: matching therapy to the patient 4 Key Takeaways: Head-to-head trials show IL-17s like ixekizumab outperform traditional TNF inhibitors and even some IL-23s in early, fast action. Precision therapy based on site (scalp, nails, genitalia) and comorbidities is now guiding real-world treatment selection. GLP-1 medications are emerging as effective adjuncts for psoriasis patients struggling with weight and inflammation. Early intervention—especially with IL-23 inhibitors—may reduce flares, limit disease progression, and improve mental health outcomes. Guest Bio: Dr. Mona Shahriari is an Associate Clinical Professor of Dermatology at Yale University and Co-Founder of Central Connecticut Dermatology. A leading voice in inflammatory skin conditions, she serves as Associate Director of Clinical Trials and Senior Editor for the Journal of Psoriasis and Psoriatic Arthritis, a National Psoriasis Foundation peer reviewed journal for health care providers. Dr. Shahriari is also a National Psoriasis Foundation Medical Board Member and frequent contributor to dermatological research and clinical education. Resources Mentioned: National Psoriasis Foundation: Subscribe to the Advance eNewsletter: AAD Annual Meeting Info: Learn More About Clinical Trials: Tags: psoriasis, psoriatic arthritis, IL-17, IL-23, biologics, personalized medicine, dermatology, GLP-1, weight management, immune memory, AAD 2025, TYK2 inhibitors, Dr. Mona Shahriari, National Psoriasis Foundation, Psound Bytes podcast, Soundbites podcast /episode/index/show/psoundbytes/id/36352050

Psoriasis Uncovered

TOPICS